Pesticidal proteins

Abstract

The subject invention concerns new classes of pesticidally active proteins and the polynucleotide sequences that encode these proteins. In preferred embodiments, these pesticidal protein have molecular weights of approximately 40-50 kDa and of approximately 10-15 kDa.

Description

BACKGROUND OF THE INVENTION

[0002] Coleopterans are a significant group of agricultural pests which cause extensive damage to crops each year. Examples of coleopteran pests include corn rootworm and alfalfa weevils.

[0003] The alfalfa weevil, Hypera postica, and the closely related Egyptian alfalfa weevil, Hypera brunneipennis, are the most important insect pests of alfalfa grown in the United States, with 2.9 million acres infested in 1984. An annual sum of 20 million dollars is spent to control these pests. The Egyptian alfalfa weevil is the predominant species in the southwestern U.S., where it undergoes aestivation (i.e., hibernation) during the hot summer months. In all other respects, it is identical to the alfalfa weevil, which predominates throughout the rest of the U.S.

[0004] The larval stage is the most damaging in the weevil life cycle. By feeding at the alfalfa plant's growing tips, the larvae cause skeletonization of leaves, stunting, reduced plant growth, and, ultimately, reductions in yield. Severe infestations can ruin an entire cutting of hay. The adults, also foliar feeders, cause additional, but less significant, damage.

[0005] Approximately 10 million acres of U.S. corn are infested with corn rootworm species complex each year. The corn rootworm species complex includes the northern corn rootworm, Diabrotica barberi, the southern corn rootworm, D. undecimpunctata howardi, and the western corn rootworm, D. virgifera virgifera. The soil-dwelling larvae of these Diabrotica species feed on the root of the corn plant, causing lodging. Lodging eventually reduces corn yield and often results in death of the plant. By feeding on cornsilks, the adult beetles reduce pollination and, therefore, detrimentally affect the yield of corn per plant. In addition, adults and larvae of the genus Diabrotica attack cucurbit crops (cucumbers, melons, squash, etc.) and many vegetable and field crops in commercial production as well as those being grown in home gardens.

[0006] Control of corn rootworm has been partially addressed by cultivation methods, such as crop rotation and the application of high nitrogen levels to stimulate the growth of an adventitious root system. However, chemical insecticides are relied upon most heavily to guarantee the desired level of control. Insecticides are either banded onto or incorporated into the soil. Problems associated with the use of some chemical insecticides are environmental contamination and the development of resistance among the treated insect populations.

[0007] The soil microbe Bacillus thuringiensis (B.t.) is a Gram-positive, spore-forming bacterium characterized by parasporal protein inclusions, which can appear microscopically as distinctively shaped crystals. Certain strains of B.t. produce proteins that are toxic to specific orders of pests. Certain B.t. toxin genes have been isolated and sequenced, and recombinant DNA-based B.t. products have been produced and approved for use. In addition, with the use of genetic engineering techniques, new approaches for delivering these B.t. endotoxins to agricultural environments are under development, including the use of plants genetically engineered with endotoxin genes for insect resistance and the use of stabilized intact microbial cells as B.t. endotoxin delivery vehicles (Gaertner, F. H., L. Kim [1988] TIBTECH 6:S4-S7). Thus, isolated B.t. endotoxin genes are becoming commercially valuable.

[0008] Commercial use of B.t. pesticides was originally limited to a narrow range of lepidopteran (caterpillar) pests. Preparations of the spores and crystals of B. thuringiensis subsp. kurstaki have been used for many years as commercial insecticides for lepidopteran pests. For example, B. thuringiensis var. kurstaki HD-1 produces a crystalline 8-endotoxin which is toxic to the larvae of a number of lepidopteran insects.

[0009] In recent years, however, investigators have discovered B.t. pesticides with specificities for a much broader range of pests. For example, other species of B.t., namely israelensis and tenebrionis (a.k.a. B.t. M-7, a.k.a. B.t. san diego), have been used commercially to control insects of the orders Diptera and Coleoptera, respectively (Gaertner, F. H. [1989] “Cellular Delivery Systems for Insecticidal Proteins: Living and Non-Living Microorganisms,” in Controlled Delivery of Crop Protection Agents, R. M. Wilkins, ed., Taylor and Francis, New York and London, 1990, pp. 245-255). See also Couch, T. L. (1980) “Mosquito Pathogenicity of Bacillus thuringiensis var. israelensis,” Developments in Industrial Microbiology 22:61-76; Beegle, C. C., (1978) “Use of Entomogenous Bacteria in Agroecosystems,” Developments in Industrial Microbiology 20:97-104. Krieg, A., A. M. Huger, G. A. Langenbruch, W. Schnetter (1983) Z. ang. Ent. 96:500-508, describe Bacillus thuringiensis var. tenebrionis, which is reportedly active against two beetles in the order Coleoptera. These are the Colorado potato beetle, Leptinotarsa decemlineata, and Agelastica alni.

[0010] Recently, new subspecies of B.t. have been identified, and genes responsible for active δ-endotoxin proteins have been isolated (Höfte, H., H. R. Whiteley [1989] Microbiological Reviews 52(2):242-255). Höfte and Whiteley classified B.t. crystal protein genes into four major classes. The classes were CryI (Lepidoptera-specific), CryII (Lepidoptera- and Diptera-specific), CryIII (Coleoptera-specific), and CryIV (Diptera-specific). The discovery of strains specifically toxic to other pests has been reported. (Feitelson, J. S., J. Payne, L. Kim [1992] Bio/Technology 10:271-275).

[0011] The 1989 nomenclature and classification scheme of Hofte and Whiteley for crystal proteins was based on both the deduced amino acid sequence and the host range of the toxin. That system was adapted to cover fourteen different types of toxin genes which were divided into five major classes. As more toxin genes were discovered, that system started to become unworkable, as genes with similar sequences were found to have significantly different insecticidal specificities. A revised nomenclature scheme has been proposed which is based solely on amino acid identity (Crickmore et al. [1996] Society for Invertebrate Pathology, 29th Annual Meeting, 3rd International Colloquium on Bacillus thuringiensis, University of Cordoba, Cordoba, Spain, September 1-6, abstract). The mnemonic “cry” has been retained for all of the toxin genes except cytA and cytB, which remain a separate class. Roman numerals have been exchanged for Arabic numerals in the primary rank, and the parentheses in the tertiary rank have been removed. Current boundaries represent approximately 95% (tertiary rank), 75% (secondary rank), and 48% (primary rank) sequence identity. Many of the original names have been retained, with the noted exceptions, although a number have been reclassified. See also N. Crickmore, D. R. Zeigler, J. Feitelson, E. Schnepf, J. Van Rie, D. Lereclus, J. Baum, and D. H. Dean (1998), “Revisions of the Nomenclature for the Bacillus thuringiensis Pesticidal Crystal Proteins,” Microbiology and Molecular Biology Reviews Vol. 62:807-813; and Crickmore, Zeigler, Feitelson, Schnepf, Van Rie, Lereclus, Baum, and Dean, “Bacillus thuringiensis toxin nomenclature” (1999) http://www.biols.susx.ac.uk/Home/Neil—Crickmore/Bt/index.html. That system uses the freely available software applications CLUSTAL W and PHYLIP. The NEIGHBOR application within the PHYLIP package uses an arithmetic averages (UPGMA) algorithm.

[0012] The cloning and expression of a B.t. crystal protein gene in Escherichia coli has been described in the published literature (Schnepf, H. E., H. R. Whiteley [1981] Proc. Natl. Acad. Sci. USA 78:2893-2897). U.S. Pat. No. 4,448,885 and U.S. Pat. No. 4,467,036 both disclose the expression of B.t. crystal protein in E. coli.

[0013] U.S. Pat. Nos. 4,797,276 and 4,853,331 disclose B. thuringiensis strain tenebrionis (a.k.a. M-7, a.k.a. B.t. san diego), which can be used to control coleopteran pests in various environments. U.S. Pat. No. 4,918,006 discloses B.t. toxins having activity against Dipterans. U.S. Pat. No. 4,849,217 discloses B.t. isolates which have activity against the alfalfa weevil. U.S. Pat. No. 5,208,077 discloses coleopteran-active Bacillus thuringiensis isolates. U.S. Pat. No. 5,632,987 discloses a 130 kDa toxin from PS80JJ1 as having activity against corn rootworm. WO 94/40162, which is related to the subject application, describes new classes of proteins that are toxic to corn rootworm. U.S. Pat. No. 5,151,363 and U.S. Pat. No. 4,948,734 disclose certain isolates of B.t. which have activity against nematodes.

[0014] U.S. Pat. No. 6,083,499 and WO 97/40162 disclose “binary toxins.” The subject invention is distinct from mosquitocidal toxins produced by Bacillus sphaericus. See EP 454 485; Davidson et al. (1990), “Interaction of the Bacillus sphaericus mosquito larvicidal proteins,” Can. J Microbiol. 36 (12):870-8; Baumann et al. (1988), “Sequence analysis of the mosquitocidal toxin genes encoding 51.4- and 41.9-kilodalton proteins from Bacillus sphaericus 2362 and 2297,” J. Bacteriol. 170:2045-2050; Oei et al. (1992), “Binding of purified Bacillus sphaericus binary toxin and its deletion derivatives to Culex quinquefasciatus gut: elucidation of functional binding domains,” Journal of General Microbiology 138 (7): 1515-26.

BRIEF SUMMARY OF THE INVENTION

[0015] The subject invention concerns novel materials and methods for controlling non-mammalian pests. In a preferred embodiment, the subject invention provides materials and methods for the control of coleopteran pests. In more preferred embodiments, the materials and methods described herein are used to control corn rootworm—most preferably Western corn rootworm. Lepidopteran pests (including the European corn borer and Helicoverpa zea) can also be controlled by the pesticidal proteins of the subject invention.

[0016] The subject invention advantageously provides polynucleotides and pesticidal proteins encoded by the polynucleotides. In preferred embodiments, a 40-50 kDa protein and a 10-15 kDa protein are used together, with the proteins being pesticidal in combination. Thus, the two classes of proteins of the subject invention can be referred to as “binary toxins.” As used herein, the term “toxin” or “pesticidal protein” includes either class of these proteins. The use of a 40-50 kDa protein with a 10-15 kDa protein is preferred but not necessarily required. One class of polynucleotide sequences as described herein encodes proteins which have a full-length molecular weight of approximately 40-50 kDa. In a specific embodiment, these proteins have a molecular weight of about 43-47 kDa. A second class of polynucleotides of the subject invention encodes pesticidal proteins of about 10-15 kDa. In a specific embodiment, these proteins have a molecular weight of about 13-14 kDa. It should be clear that each type of toxin/gene is an aspect of the subject invention. In a particularly preferred embodiment, a 40-50 kDa protein of the subject invention is used in combination with a 10-15 kDa protein. Thus, the proteins of the subject invention can be used to augment and/or facilitate the activity of other protein toxins.

[0017] The subject invention includes polynucleotides that encode the 40-50 kDa or the 10-15 kDa toxins, polynucleotides that encode portions or fragments of the full length toxins that retain pesticidal activity (preferably when used in combination), and polynucleotides that encode both types of toxins. Novel examples of fusion proteins (a 40-50 kDa protein and a 10-15 kDa protein fused together) and polynucleotides that encode them are also disclosed herein.

[0018] In some embodiments, B.t. toxins useful according to the invention include toxins which can be obtained from the novel B.t. isolates disclosed herein. It should be clear that, where 40-50 kDa and 10-15 kDa toxins, for example, are used together, one type of toxin can be obtained from one isolate and the other type of toxin can be obtained from another isolate.

[0019] The subject invention also includes the use of variants of the exemplified B.t. isolates and toxins which have substantially the same coleopteran-active properties as the specifically exemplified B.t. isolates and toxins. Such variant isolates would include, for example, mutants. Procedures for making mutants are well known in the microbiological art. Ultraviolet light and chemical mutagens such as nitrosoguanidine are used extensively toward this end.

[0020] In preferred embodiments, the subject invention concerns plants and plant cells having at least one isolated polynucleotide of the subject invention. Preferably, the transgenic plant cells express pesticidal toxins in tissues consumed by the target pests.

[0021] Alternatively, the B.t. isolates of the subject invention, or recombinant microbes expressing the toxins described herein, can be used to control pests. In this regard, the invention includes the treatment of substantially intact B.t. cells, and/or recombinant cells containing the expressed toxins of the invention, treated to prolong the pesticidal activity when the substantially intact cells are applied to the environment of a target pest. The treated cell acts as a protective coating for the pesticidal toxin.

[0022] The toxins of the subject invention are oral intoxicants that affect an insect's midgut cells upon ingestion by the target insect. Thus, by consuming recombinant host cells, for example, that express the toxins, the target insect thereby contacts the proteins of the subject invention, which are toxic to the pest. This results in control of the target pest.

BRIEF DESCRIPTION OF THE DRAWINGS

[0023] FIG. 1 shows three exemplary 43-47 kDa pesticidal toxins as well as a consensus sequence for these pesticidal toxins.

[0024] FIG. 2 shows the relationship of the 14 and 45 kDa sequences of PS80JJ1 (SEQ ID NOS. 31 and 10).

[0025] FIG. 3 shows a comparison of LC50 values from the mixing study of Example 23.

[0026] FIG. 4 shows protein alignments of the 51 and 42 kDa Bacillus sphaericus toxins and genes and the 45 kDa 149B1 toxin and gene.

[0027] FIG. 5 shows nucleotide sequence alignments of the 51 and 42 kDa Bacillus sphaericus toxins and genes and the 45 kDa 149B1 toxin and gene.

BRIEF DESCRIPTION OF THE SEQUENCES

[0028] SEQ ID NO:1 is a 5-amino acid N-terminal sequence of the approximately 45 kDa toxin of 80JJ1.

[0029] SEQ ID NO:2 is a 25-amino acid N-terminal sequence of the approximately 45 kDa toxin of 80JJ1.

[0030] SEQ ID NO:3 is a 24-amino acid N-terminal sequence of the approximately 14 kDa toxin of 80JJ1.

[0031] SEQ ID NO:4 is the N-terminal sequence of the approximately 47 kDa toxin from 149B1.

[0032] SEQ ID NO:5 is a 50-amino acid N-terminal amino acid sequence for the purified approximately 14 kDa protein from PS149B1.

[0033] SEQ ID NO:6 is the N-terminal sequence of the approximately 47 kDa toxin from 167H2.

[0034] SEQ ID NO:7 is a 25-amino acid N-terminal sequence for the purified approximately 14 kDa protein from PS167H2.

[0035] SEQ ID NO:8 is an oligonucleotide probe for the gene encoding the PS80JJ1 44.3 kDa toxin and is a forward primer for PS149B1 and PS167H2 used according to the subject invention.

[0036] SEQ ID NO:9 is a reverse primer for PS149B1 and PS167H2 used according to the subject invention.

[0037] SEQ ID NO:10 is the nucleotide sequence of the gene encoding the approximately 45 kDa PS80JJ1 toxin.

[0038] SEQ ID NO:11 is the amino acid sequence for the approximately 45 kDa PS80JJ1 toxin.

[0039] SEQ ID NO:12 is the partial nucleotide sequence of the gene encoding the approximately 44 kDa PS149B1 toxin.

[0040] SEQ ID NO:13 is the partial amino acid sequence for the approximately 44 kDa PS149B1 toxin.

[0041] SEQ ID NO:14 is the partial nucleotide sequence of the gene encoding the approximately 44 kDa PS167H2 toxin.

[0042] SEQ ID NO:15 is the partial amino acid sequence for the approximately 44 kDa PS167H2 toxin.

[0043] SEQ ID NO:16 is a peptide sequence used in primer design according to the subject invention.

[0044] SEQ ID NO:17 is a peptide sequence used in primer design according to the subject invention.

[0045] SEQ ID NO:18 is a peptide sequence used in primer design according to the subject invention.

[0046] SEQ ID NO:19 is a peptide sequence used in primer design according to the subject invention.

[0047] SEQ ID NO:20 is a nucleotide sequence corresponding to the peptide of SEQ ID NO:16.

[0048] SEQ ID NO:21 is a nucleotide sequence corresponding to the peptide of SEQ ID NO:17.

[0049] SEQ ID NO:22 is a nucleotide sequence corresponding to the peptide of SEQ ID NO:18.

[0050] SEQ ID NO:23 is a nucleotide sequence corresponding to the peptide of SEQ ID NO:19.

[0051] SEQ ID NO:24 is a reverse primer based on the reverse complement of SEQ ID NO:22.

[0052] SEQ ID NO:25 is a reverse primer based on the reverse complement of SEQ ID NO:23.

[0053] SEQ ID NO:26 is a forward primer based on the PS80JJ1 44.3 kDa toxin.

[0054] SEQ ID NO:27 is a reverse primer based on the PS80JJ1 44.3 kDa toxin.

[0055] SEQ ID NO:28 is a generic sequence representing a new class of toxins according to the subject invention.

[0056] SEQ ID NO:29 is an oligonucleotide probe used according to the subject invention.

[0057] SEQ ID NO:30 is the nucleotide sequence of the entire genetic locus containing open reading frames of both the 14 and 45 kDa PS80JJ1 toxins and the flanking nucleotide sequences.

[0058] SEQ ID NO:31 is the nucleotide sequence of the PS80JJ1 14 kDa toxin open reading frame.

[0059] SEQ ID NO:32 is the deduced amino acid sequence of the 14 kDa toxin of PS80JJ1.

[0060] SEQ ID NO:33 is a reverse oligonucleotide primer used according to the subject invention.

[0061] SEQ ID NO:34 is the nucleotide sequence of the entire genetic locus containing open reading frames of both the 14 and 44 kDa PS167H2 toxins and the flanking nucleotide sequences.

[0062] SEQ ID NO:35 is the nucleotide sequence of the gene encoding the approximately 14 kDa PS167H2 toxin.

[0063] SEQ ID NO:36 is the amino acid sequence for the approximately 14 kDa PS167H2 toxin.

[0064] SEQ ID NO:37 is the nucleotide sequence of the gene encoding the approximately 44 kDa PS167H2 toxin.

[0065] SEQ ID NO:38 is the amino acid sequence for the approximately 44 kDa PS167H2 toxin.

[0066] SEQ ID NO:39 is the nucleotide sequence of the entire genetic locus containing open reading frames of both the 14 and 44 kDa PS149B1 toxins and the flanking nucleotide sequences.

[0067] SEQ ID NO:40 is the nucleotide sequence of the gene encoding the approximately 14 kDa PS149B1 toxin.

[0068] SEQ ID NO:41 is the amino acid sequence for the approximately 14 kDa PS149B1 toxin.

[0069] SEQ ID NO:42 is the nucleotide sequence of the gene encoding the approximately 44 kDa PS149B1 toxin.

[0070] SEQ ID NO:43 is the amino acid sequence for the approximately 44 kDa PS149B1 toxin.

[0071] SEQ ID NO:44 is a maize-optimized gene sequence encoding the approximately 14 kDa toxin of 80JJ1.

[0072] SEQ ID NO:45 is a maize-optimized gene sequence encoding the approximately 44 kDa toxin of 80JJ1.

[0073] SEQ ID NO:46 is the DNA sequence of a reverse primer used in Example 15, below.

[0074] SEQ ID NO:47 is the DNA sequence of a forward primer (see Example 16).

[0075] SEQ ID NO:48 is the DNA sequence of a reverse primer (see Example 16).

[0076] SEQ ID NO:49 is the DNA sequence of a forward primer (see Example 16).

[0077] SEQ ID NO:50 is the DNA sequence of a reverse primer (see Example 16).

[0078] SEQ ID NO:51 is the DNA sequence from PS131W2 which encodes the 14 kDa protein.

[0079] SEQ ID NO:52 is the amino acid sequence of the 14 kDa protein of PS131W2.

[0080] SEQ ID NO:53 is a partial DNA sequence from PS131W2 for the 44 kDa protein.

[0081] SEQ ID NO:54 is a partial amino acid sequence for the 44 kDa protein of PS131W2.

[0082] SEQ ID NO:55 is the DNA sequence from PS158T3 which encodes the 14 kDa protein.

[0083] SEQ ID NO:56 is the amino acid sequence of the 14 kDa protein of PS158T3.

[0084] SEQ ID NO:57 is a partial DNA sequence from PS158T3 for the 44 kDa protein.

[0085] SEQ ID NO:58 is a partial amino acid sequence for the 44 kDa protein of PS158T3.

[0086] SEQ ID NO:59 is the DNA sequence from PS158X10 which encodes the 14 kDa protein.

[0087] SEQ ID NO:60 is the amino acid sequence of the 14 kDa protein of PS158X10.

[0088] SEQ ID NO:61 is the DNA sequence from PS185FF which encodes the 14 kDa protein.

[0089] SEQ ID NO:62 is the amino acid sequence of the 14 kDa protein of PS185FF.

[0090] SEQ ID NO:63 is a partial DNA sequence from PS185FF for the 44 kDa protein.

[0091] SEQ ID NO:64 is a partial amino acid sequence for the 44 kDa protein of PS185FF.

[0092] SEQ ID NO:65 is the DNA sequence from PS185GG which encodes the 14 kDa protein.

[0093] SEQ ID NO:66 is the amino acid sequence of the 14 kDa protein of PS185GG.

[0094] SEQ ID NO:67 is the DNA sequence from PS185GG for the 44 kDa protein.

[0095] SEQ ID NO:68 is the amino acid sequence for the 44 kDa protein of PS185GG.

[0096] SEQ ID NO:69 is the DNA sequence from PS185L12 which encodes the 14 kDa protein.

[0097] SEQ ID NO:70 is the amino acid sequence of the 14 kDa protein of PS185L12.

[0098] SEQ ID NO:71 is the DNA sequence from PS185W3 which encodes the 14 kDa protein.

[0099] SEQ ID NO:72 is the amino acid sequence of the 14 kDa protein of PS185W3.

[0100] SEQ ID NO:73 is the DNA sequence from PS186FF which encodes the 14 kDa protein.

[0101] SEQ ID NO:74 is the amino acid sequence of the 14 kDa protein of PS186FF.

[0102] SEQ ID NO:75 is the DNA sequence from PS187F3 which encodes the 14 kDa protein.

[0103] SEQ ID NO:76 is the amino acid sequence of the 14 kDa protein of PS187F3.

[0104] SEQ ID NO:77 is a partial DNA sequence from PS187F3 for the 44 kDa protein.

[0105] SEQ ID NO:78 is a partial amino acid sequence for the 44 kDa protein of PS187F3.

[0106] SEQ ID NO:79 is the DNA sequence from PS187G1 which encodes the 14 kDa protein.

[0107] SEQ ID NO:80 is the amino acid sequence of the 14 kDa protein of PS187G1.

[0108] SEQ ID NO:81 is a partial DNA sequence from PS187G1 for the 44 kDa protein.

[0109] SEQ ID NO:82 is a partial amino acid sequence for the 44 kDa protein of PS187G1.

[0110] SEQ ID NO:83 is the DNA sequence from PS187L14 which encodes the 14 kDa protein.

[0111] SEQ ID NO:84 is the amino acid sequence of the 14 kDa protein of PS187L14.

[0112] SEQ ID NO:85 is a partial DNA sequence from PS187L14 for the 44 kDa protein.

[0113] SEQ ID NO:86 is a partial amino acid sequence for the 44 kDa protein of PS187L14.

[0114] SEQ ID NO:87 is the DNA sequence from PS187Y2 which encodes the 14 kDa protein.

[0115] SEQ ID NO:88 is the amino acid sequence of the 14 kDa protein of PS187Y2.

[0116] SEQ ID NO:89 is a partial DNA sequence from PS187Y2 for the 44 kDa protein.

[0117] SEQ ID NO:90 is a partial amino acid sequence for the 44 kDa protein of PS187Y2.

[0118] SEQ ID NO:91 is the DNA sequence from PS201G which encodes the 14 kDa protein.

[0119] SEQ ID NO:92 is the amino acid sequence of the 14 kDa protein of PS201 G.

[0120] SEQ ID NO:93 is the DNA sequence from PS201HH which encodes the 14 kDa protein.

[0121] SEQ ID NO:94 is the amino acid sequence of the 14 kDa protein of PS201HH.

[0122] SEQ ID NO:95 is the DNA sequence from PS201L3 which encodes the 14 kDa protein.

[0123] SEQ ID NO:96 is the amino acid sequence of the 14 kDa protein of PS201L3.

[0124] SEQ ID NO:97 is the DNA sequence from PS204C3 which encodes the 14 kDa protein.

[0125] SEQ ID NO:98 is the amino acid sequence of the 14 kDa protein of PS204C3.

[0126] SEQ ID NO:99 is the DNA sequence from PS204G4 which encodes the 14 kDa protein.

[0127] SEQ ID NO:100 is the amino acid sequence of the 14 kDa protein of PS204G4.

[0128] SEQ ID NO:101 is the DNA sequence from PS204I11 which encodes the 14 kDa protein.

[0129] SEQ ID NO:102 is the amino acid sequence of the 14 kDa protein of PS204I11.

[0130] SEQ ID NO:103 is the DNA sequence from PS204J7 which encodes the 14 kDa protein.

[0131] SEQ ID NO:104 is the amino acid sequence of the 14 kDa protein of PS204J7.

[0132] SEQ ID NO:105 is the DNA sequence from PS236B6 which encodes the 14 kDa protein.

[0133] SEQ ID NO:106 is the amino acid sequence of the 14 kDa protein of PS236B6.

[0134] SEQ ID NO:107 is the DNA sequence from PS242K10 which encodes the 14 kDa protein.

[0135] SEQ ID NO:108 is the amino acid sequence of the 14 kDa protein of PS242K10.

[0136] SEQ ID NO:109 is a partial DNA sequence from PS242K10 for the 44 kDa protein.

[0137] SEQ ID NO:110 is a partial amino acid sequence for the 44 kDa protein of PS242K10.

[0138] SEQ ID NO:111 is the DNA sequence from PS246P42 which encodes the 14 kDa protein.

[0139] SEQ ID NO:112 is the amino acid sequence of the 14 kDa protein of PS246P42.

[0140] SEQ ID NO:113 is the DNA sequence from PS69Q which encodes the 14 kDa protein.

[0141] SEQ ID NO:114 is the amino acid sequence of the 14 kDa protein of PS69Q.

[0142] SEQ ID NO:115 is the DNA sequence from PS69Q for the 44 kDa protein.

[0143] SEQ ID NO:116 is the amino acid sequence for the 44 kDa protein of PS69Q.

[0144] SEQ ID NO:117 is the DNA sequence from KB54 which encodes the 14 kDa protein.

[0145] SEQ ID NO:118 is the amino acid sequence of the 14 kDa protein of KB54.

[0146] SEQ ID NO:119 is the DNA sequence from KR1209 which encodes the 14 kDa protein.

[0147] SEQ ID NO:120 is the amino acid sequence of the 14 kDa protein of KR1209.

[0148] SEQ ID NO:121 is the DNA sequence from KR1369 which encodes the 14 kDa protein.

[0149] SEQ ID NO:122 is the amino acid sequence of the 14 kDa protein of KR1369.

[0150] SEQ ID NO:123 is the DNA sequence from KR589 which encodes the 14 kDa protein.

[0151] SEQ ID NO:124 is the amino acid sequence of the 14 kDa protein of KR589.

[0152] SEQ ID NO:125 is a partial DNA sequence from KR589 for the 44 kDa protein.

[0153] SEQ ID NO:126 is a partial amino acid sequence for the 44 kDa protein of KR589.

[0154] SEQ ID NO:127 is a polynucleotide sequence for a gene designated 149B1-15-PO, which is optimized for expression in Zea mays. This gene encodes an approximately 15 kDa toxin obtainable from PS149B1 that is disclosed in WO 97/40162.

[0155] SEQ ID NO:128 is a polynucleotide sequence for a gene designated 149B1-45-PO, which is optimized for expression in Zea mays. This gene encodes an approximately 45 kDa toxin obtainable from PS149B1 that is disclosed in WO 97/40162.

[0156] SEQ ID NO:129 is a polynucleotide sequence for a gene designated 80JJ1-15-PO7, which is optimized for expression in maize. This is an alternative gene that encodes an approximately 15 kDa toxin.

[0157] SEQ ID NO:130 is an amino acid sequence for a toxin encoded by the gene designated 80JJ1-15-PO7.

[0158] SEQ ID NO:131 is an oligonucleotide primer (15 kfor1) used according to the subject invention (see Example 20).

[0159] SEQ ID NO:132 is an oligonucleotide primer (45krev6) used according to the subject invention (see Example 20).

[0160] SEQ ID NO:133 is the DNA sequence from PS201L3 which encodes the 14 kDa protein.

[0161] SEQ ID NO:134 is the amino acid sequence of the 14 kDa protein of PS201 L3.

[0162] SEQ ID NO:135 is a DNA sequence from PS201L3 for the 44 kDa protein.

[0163] SEQ ID NO:136 is an amino acid sequence for the 44 kDa protein of PS201 L3.

[0164] SEQ ID NO:137 is the DNA sequence from PS187G1 which encodes the 14 kDa protein.

[0165] SEQ ID NO:138 is the amino acid sequence of the 14 kDa protein of PS187G1.

[0166] SEQ ID NO:139 is the DNA sequence from PS187G1 which encodes the 44 kDa protein.

[0167] SEQ ID NO:140 is the amino acid sequence of the 44 kDa protein of PS187G1.

[0168] SEQ ID NO:141 is the DNA sequence from PS201HH2 which encodes the 14 kDa protein.

[0169] SEQ ID NO:142 is the amino acid sequence of the 14 kDa protein of PS201HH2.

[0170] SEQ ID NO:143 is a partial DNA sequence from PS201HH2 for the 44 kDa protein.

[0171] SEQ ID NO:144 is a partial amino acid sequence for the 44 kDa protein of PS201HH2.

[0172] SEQ ID NO:145 is the DNA sequence from KR1369 which encodes the 14 kDa protein.

[0173] SEQ ID NO:146 is the amino acid sequence of the 14 kDa protein of KR1369.

[0174] SEQ ID NO:147 is the DNA sequence from KR1369 which encodes the 44 kDa protein.

[0175] SEQ ID NO:148 is the amino acid sequence of the 44 kDa protein of KR1369.

[0176] SEQ ID NO:149 is the DNA sequence from PS137A which encodes the 14 kDa protein.

[0177] SEQ ID NO:150 is the amino acid sequence of the 14 kDa protein of PS137A.

[0178] SEQ ID NO:151 is the DNA sequence from PS201V2 which encodes the 14 kDa protein.

[0179] SEQ ID NO:152 is the amino acid sequence of the 14 kDa protein of PS201V2.

[0180] SEQ ID NO:153 is the DNA sequence from PS207C3 which encodes the 14 kDa protein.

[0181] SEQ ID NO:154 is the amino acid sequence of the 14 kDa protein of PS207C3.

[0182] SEQ ID NO:155 is an oligonucleotide primer (F1new) for use according to the subject invention (see Example 22).

[0183] SEQ ID NO:156 is an oligonucleotide primer (R1new) for use according to the subject invention (see Example 22).

[0184] SEQ ID NO:157 is an oligonucleotide primer (F2new) for use according to the subject invention (see Example 22).

[0185] SEQ ID NO:158 is an oligonucleotide primer (R2new) for use according to the subject invention (see Example 22).

[0186] SEQ ID NO:159 is an approximately 58 kDa fusion protein.

[0187] SEQ ID NO:160 is a fusion gene encoding the protein of SEQ ID NO:159.

[0188] SEQ ID NO:161 is primer 45 kD5′ for use according to the subject invention (see Example 27).

[0189] SEQ ID NO:162 is primer 45 kD3′rc for use according to the subject invention (see Example 27).

[0190] SEQ ID NO:163 is primer 45 kD5′01 for use according to the subject invention (see Example 27).

[0191] SEQ ID NO:164 is primer 45 kD5′02 for use according to the subject invention (see Example 27).

[0192] SEQ ID NO:165 is primer 45 kD3′03 for use according to the subject invention (see Example 27).

[0193] SEQ ID NO:166 is primer 45 kD3′04 for use according to the subject invention (see Example 27).

DETAILED DISCLOSURE OF THE INVENTION

[0194] The subject invention concerns two new classes of polynucleotide sequences as well as the novel pesticidal proteins encoded by these polynucleotides. In one embodiment, the proteins have a full-length molecular weight of approximately 40-50 kDa. In specific embodiments exemplified herein, these proteins have a molecular weight of about 43-47 kDa. In a second embodiment, the pesticidal proteins have a molecular weight of approximately 10-15 kDa. In specific embodiments exemplified herein, these proteins have a molecular weight of about 13-14 kDa.

[0195] In preferred embodiments, a 40-50 kDa protein and a 10-15 kDa protein are used together, and the proteins are pesticidal in combination. Thus, the two classes of proteins of the subject invention can be referred to as “binary toxins.” As used herein, the term “toxin” includes either class of pesticidal proteins. The subject invention concerns polynucleotides which encode either the 40-50 kDa or the 10-15 kDa toxins, polynucleotides which encode portions or fragments of the full length toxins that retain pesticidal activity when used in combination, and polynucleotide sequences which encode both types of toxins. In a preferred embodiment, these toxins are active against coleopteran pests, more preferably corn rootworm, and most preferably Western corn rootworm. Lepidopteran pests can also be targeted.

[0196] Certain specific toxins are exemplified herein. For toxins having a known amino acid sequence, the molecular weight is also known. Those skilled in the art will recognize that the apparent molecular weight of a protein as determined by gel electrophoresis will sometimes differ from the true molecular weight. Therefore, reference herein to, for example, a 45 kDa protein or a 14 kDa protein is understood to refer to proteins of approximately that size even if the true molecular weight is somewhat different.

[0197] The subject invention concerns not only the polynucleotides that encode these classes of toxins, but also the use of these polynucleotides to produce recombinant hosts which express the toxins. In a further aspect, the subject invention concerns the combined use of an approximately 40-50 kDa toxin of the subject invention together with an approximately 10-15 kDa toxin of the subject invention to achieve highly effective control of pests, including coleopterans such as corn rootworm. For example, the roots of one plant can express both types of toxins.

[0198] Thus, control of pests using the isolates, toxins, and genes of the subject invention can be accomplished by a variety of methods known to those skilled in the art. These methods include, for example, the application of B.t. isolates to the pests (or their location), the application of recombinant microbes to the pests (or their locations), and the transformation of plants with genes which encode the pesticidal toxins of the subject invention. Microbes for use according to the subject invention maybe, for example, B.t., E. coli, and/or Pseudomonas. Recombinant hosts can be made by those skilled in the art using standard techniques. Materials necessary for these transformations are disclosed herein or are otherwise readily available to the skilled artisan. Control of insects and other pests such as nematodes and mites can also be accomplished by those skilled in the art using standard techniques combined with the teachings provided herein.

[0199] The new classes of toxins and polynucleotide sequences provided here are defined according to several parameters. One critical characteristic of the toxins described herein is pesticidal activity. In a specific embodiment, these toxins have activity against coleopteran pests. Anti-lepidopteran-active toxins are also embodied. The toxins and genes of the subject invention can be further defined by their amino acid and nucleotide sequences. The sequences of the molecules within each novel class can be identified and defined in terms of their similarity or identity to certain exemplified sequences as well as in terms of the ability to hybridize with, or be amplified by, certain exemplified probes and primers. The classes of toxins provided herein can also be identified based on their immunoreactivity with certain antibodies and based upon their adherence to a generic formula.

[0200] It should be apparent to a person skilled in this art that genes encoding pesticidal proteins according to the subject invention can be obtained through several means. The specific genes exemplified herein may be obtained from the isolates deposited at a culture depository as described herein. These genes, and toxins, of the subject invention can also be constructed synthetically, for example, by the use of a gene synthesizer.

[0201] The sequence of three exemplary 45 kDa toxins are provided as SEQ ID NOS:11, 43, and 38. In preferred embodiments, toxins of this class have a sequence which conforms to the generic sequence presented as SEQ ID NO:28. In preferred embodiments, the toxins of this class will conform to the consensus sequence shown in FIG. 1.

[0202] With the teachings provided herein, one skilled in the art could readily produce and use the various toxins and polynucleotide sequences of the novel classes described herein.

[0203] Microorganisms useful according to the subject invention have been deposited in the permanent collection of the Agricultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Ill. 61604, USA. The culture repository numbers of the deposited strains are as follows:

Culture	Repository No.	Deposit Date
B.t. strain PS80JJ1	NRRL B-18679	Jul. 17, 1990
B.t. strain PS149B1	NRRL B-21553	Mar. 28, 1996
B.t. strain PS167H2	NRRL B-21554	Mar. 28, 1996
E. coli NM522 (pMYC2365)	NRRL B-21170	Jan. 5, 1994
E. coli NM522 (pMYC2382)	NRRL B-21329	Sep. 28, 1994
E. coli NM522 (pMYC2379)	NRRL B-21155	Nov. 3, 1993
E. coli NM522(pMYC2421)	NRRL B-21555	Mar. 28, 1996
E. coli NM522(pMYC2427)	NRRL B-21672	Mar. 26, 1997
E. coli NM522(pMYC2429)	NRRL B-21673	Mar. 26, 1997
E. coli NM522(pMYC2426)	NRRL B-21671	Mar. 26, 1997
B.t. strain PS185GG	NRRL B-30175	Aug. 19, 1999
B.t. strain PS187G1	NRRL B-30185	Aug. 19, 1999
B.t. strain PS187Y2	NRRL B-30187	Aug. 19, 1999
B.t. strain PS201G	NRRL B-30188	Aug. 19, 1999
B.t. strain PS201HH2	NRRL B-30190	Aug. 19, 1999
B.t. strain PS242K10	NRRL B-30195	Aug. 19, 1999
B.t. strain PS69Q	NRRL B-30175	Aug. 19, 1999
B.t. strain KB54A1-6	NRRL B-30197	Aug. 19, 1999
B.t. strain KR589	NRRL B-30198	Aug. 19, 1999
B.t. strain PS185L12	NRRL B-30179	Aug. 19, 1999
B.t. strain PS185W3	NRRL B-30180	Aug. 19, 1999
B.t. strain PS187L14	NRRL B-30186	Aug. 19, 1999
B.t. strain PS186FF	NRRL B-30182	Aug. 19, 1999
B.t. strain PS131W2	NRRL B-30176	Aug. 19, 1999
B.t. strain PS158T3	NRRL B-30177	Aug. 19, 1999
B.t. strain PS158X10	NRRL B-30178	Aug. 19, 1999
B.t. strain PS185FF	NRRL B-30182	Aug. 19, 1999
B.t. strain PS187F3	NRRL B-30184	Aug. 19, 1999
B.t. strain PS201L3	NRRL B-30189	Aug. 19, 1999
B.t. strain PS204C3	NRRL B-30191	Aug. 19, 1999
B.t. strain PS204G4	NRRL B-18685	Jul. 17, 1990
B.t. strain PS204I11	NRRL B-30192	Aug. 19, 1999
B.t. strain PS204J7	NRRL B-30193	Aug. 19, 1999
B.t. strain PS236B6	NRRL B-30194	Aug. 19, 1999
B.t. strain PS246P42	NRRL B-30196	Aug. 19, 1999
B.t. strain KR1209	NRRL B-30199	Aug. 19, 1999
B.t. strain KR1369	NRRL B-30200	Aug. 19, 1999
B.t. strain MR1506	NRRL B-30298	June 1, 2000
B.t. strain MR1509	NRRL B-30330	Aug. 8, 2000
B.t. strain MR1510	NRRL B-30331	Aug. 8, 2000
P.f. strain MR1607	NRRL B-30332	Aug. 8, 2000

[0204] The PS80JJ1 isolate is available to the public by virtue of the issuance of U.S. Pat. No. 5,151,363 and other patents.

[0205] A further aspect of the subject invention concerns novel isolates and the toxins and genes obtainable from these isolates. Novel isolates have been deposited and are included in the above list. These isolates have been deposited under conditions that assure that access to the cultures will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 CFR 1.14 and 35 U.S.C. 122. The deposits are available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny, are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.

[0206] Further, the subject culture deposits will be stored and made available to the public in accord with the provisions of the Budapest Treaty for the Deposit of Microorganisms, i.e., they will be stored with all the care necessary to keep them viable and uncontaminated for a period of at least five years after the most recent request for the furnishing of a sample of a deposit, and in any case, for a period of at least 30 (thirty) years after the date of deposit or for the enforceable life of any patent which may issue disclosing the cultures. The depositor acknowledges the duty to replace the deposit(s) should the depository be unable to furnish a sample when requested, due to the condition of the deposit(s). All restrictions on the availability to the public of the subject culture deposits will be irrevocably removed upon the granting of a patent disclosing them.

[0207] Following is a table which provides characteristics of certain B.t. isolates that are useful according to the subject invention.

TABLE 1
Description of B.t. strains toxic to coleopterans
	Crystal	Approx. MW		NRRL	Deposit
Culture	Description	(kDa)	Serotype	Deposit	Date
PS80JJ1	multiple attached	130, 90, 47, 37, 14	4a4b, sotto	B-18679	Jul. 7, 1990
PS149B1		130, 47, 14		B-21553	Mar. 28, 1996
PS167H2		70, 47, 14		B-23554	Mar. 28, 1996

[0208] Other isolates of the subject invention can also be characterized in terms of the shape and location of toxin inclusions.

[0209] Toxins, genes, and probes. The polynucleotides of the subject invention can be used to form complete “genes” to encode proteins or peptides in a desired host cell. For example, as the skilled artisan would readily recognize, some of the polynucleotides in the attached sequence listing are shown without stop codons. Also, the subject polynucleotides can be appropriately placed under the control of a promoter in a host of interest, as is readily known in the art.

[0210] As the skilled artisan would readily recognize, DNA typically exists in a double-stranded form. In this arrangement, one strand is complementary to the other strand and vice versa. As DNA is replicated in a plant (for example) additional, complementary strands of DNA are produced. The “coding strand” is often used in the art to refer to the strand that binds with the anti-sense strand. The mRNA is transcribed from the “anti-sense” strand of DNA. The “sense” or “coding” strand has a series of codons (a codon is three nucleotides that can be read three-at-a-time to yield a particular amino acid) that can be read as an open reading frame (ORF) to form a protein or peptide of interest. In order to express a protein in vivo, a strand of DNA is typically transcribed into a complementary strand of mRNA which is used as the template for the protein. Thus, the subject invention includes the use of the exemplified polynucleotides shown in the attached sequence listing and/or the complementary strands. RNA and PNA (peptide nucleic acids) that are functionally equivalent to the exemplified DNA are included in the subject invention.

[0211] Toxins and genes of the subject invention can be identified and obtained by using oligonucleotide probes, for example. These probes are detectable nucleotide sequences which may be detectable by virtue of an appropriate label or may be made inherently fluorescent as described in International Application No. WO 93/16094. The probes (and the polynucleotides of the subject invention) may be DNA, RNA, or PNA. In addition to adenine (A), cytosine (C), guanine (G), thymine (T), and uracil (U; for RNA molecules), synthetic probes (and polynucleotides) of the subject invention can also have inosine (a neutral base capable of pairing with all four bases; sometimes used in place of a mixture of all four bases in synthetic probes). Thus, where a synthetic, degenerate oligonucleotide is referred to herein, and “n” is used generically, “n” can be G, A, T, C, or inosine. Ambiguity codes as used herein are in accordance with standard IUPAC naming conventions as of the filing of the subject application (for example, R means A or G, Y means C or T, etc.)

[0212] As is well known in the art, if the probe molecule and nucleic acid sample hybridize by forming a strong bond between the two molecules, it can be reasonably assumed that the probe and sample have substantial homology/similarity/identity. Preferably, hybridization is conducted under stringent conditions by techniques well-known in the art, as described in, for example, Keller, G. H., M. M. Manak (11987) DNA Probes, Stockton Press, New York, N.Y., pp. 169-170. For example, as stated therein, high stringency conditions can be achieved by first washing with 2×SSC (Standard Saline Citrate)/0.1% SDS (Sodium Dodecyl Sulfate) for 15 minutes at room temperature. Two washes are typically performed. Higher stringency can then be achieved by lowering the salt concentration and/or by raising the temperature. For example, the wash described above can be followed by two washings with 0.1×SSC/0.1% SDS for 15 minutes each at room temperature followed by subsequent washes with 0.1×SSC/0.1% SDS for 30 minutes each at 55° C. These temperatures can be used with other hybridization and wash protocols set forth herein and as would be known to one skilled in the art (SSPE can be used as the salt instead of SSC, for example). The 2×SSC/0.1% SDS can be prepared by adding 50 ml of 20×SSC and 5 ml of 10% SDS to 445 ml of water. 20×SSC can be prepared by combining NaCl (175.3 g/0.150 M), sodium citrate (88.2 g/0.015 M), and water to 1 liter, followed by adjusting pH to 7.0 with 10 N NaOH. 10% SDS can be prepared by dissolving 10 g of SDS in 50 ml of autoclaved water, diluting to 100 ml, and aliquotting.

[0213] Detection of the probe provides a means for determining in a known manner whether hybridization has occurred. Such a probe analysis provides a rapid method for identifying toxin-encoding genes of the subject invention. The nucleotide segments which are used as probes according to the invention can be synthesized using a DNA synthesizer and standard procedures. These nucleotide sequences can also be used as PCR primers to amplify genes of the subject invention.

[0214] Hybridization characteristics of a molecule can be used to define polynucleotides of the subject invention. Thus the subject invention includes polynucleotides (and/or their complements, preferably their full complements) that hybridize with a polynucleotide exemplified herein (such as the DNA sequences included in SEQ ID NOs:46-166).

[0215] As used herein “stringent” conditions for hybridization refers to conditions which achieve the same, or about the same, degree of specificity of hybridization as the conditions employed by the current applicants. Specifically, hybridization of immobilized DNA on Southern blots With 32P-labeled gene-specific probes was performed by standard methods (Maniatis, T., E. F. Fritsch, J. Sambrook [1982] Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.). In general, hybridization and subsequent washes were carried out under stringent conditions that allowed for detection of target sequences (with homology to the PS80JJ1 toxin genes, for example). For double-stranded DNA gene probes, hybridization was carried out overnight at 20-25° C. below the melting temperature (Tm) of the DNA hybrid in 6×SSPE, 5× Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. The melting temperature is described by the following formula (Beltz, G. A., K. A. Jacobs, T. H. Eickbush, P. T. Cherbas, and F. C. Kafatos [1983] Methods of Enzymology, R. Wu, L. Grossman and K. Moldave [eds.] Academic Press, New York 100:266-285):

[0216] Tm=81.5° C.+16.6 Log[Na+]+0.41 (% G+C)-0.61 (% formamide)-600/length of duplex in base pairs.

[0217] Washes are typically carried out as follows:

[0218] (1) Twice at room temperature for 15 minutes in 1×SSPE, 0.1% SDS (low stringency wash).

[0219] (2) Once at Tm-20° C. for 15 minutes in 0.2×SSPE, 0.1% SDS (moderate stringency wash).

[0220] For oligonucleotide probes, hybridization was carried out overnight at 10-20° C. below the melting temperature (Tm) of the hybrid in 6×SSPE, 5× Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. Tm for oligonucleotide probes was determined by the following formula:

[0221] Tm (° C.)=2 (number T/A base pairs)+4 (number G/C base pairs)

[0222] (Suggs, S. V., T. Miyake, E. H. Kawashime, M. J. Johnson, K. Itakura, and R. B. Wallace [1981] ICN-UCLA Symp. Dev. Biol. Using Purified Genes, D. D. Brown [ed.], Academic Press, New York, 23:683-693).

[0223] Washes were typically carried out as follows:

[0224] (1) Twice at room temperature for 15 minutes 1×SSPE, 0.1% SDS (low stringency wash).

[0225] (2) Once at the hybridization temperature for 15 minutes in 1×SSPE, 0.1% SDS (moderate stringency wash).

[0226] Toxins obtainable from isolates PS149B1, PS167H2, and PS80JJ1 have been characterized as having have at least one of the following characteristics (novel toxins of the subject invention can be similarly characterized with this and other identifying information set forth herein):

[0227] (a) said toxin is encoded by a nucleotide sequence which hybridizes under stringent conditions with a nucleotide sequence selected from the group consisting of: DNA which encodes SEQ ID NO:2, DNA which encodes SEQ ID NO:4, DNA which encodes SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, DNA which encodes SEQ ID NO:11, SEQ ID NO:12, DNA which encodes SEQ ID NO:13, SEQ ID NO:14, DNA which encodes SEQ ID NO:15, DNA which encodes SEQ ID NO:16, DNA which encodes SEQ ID NO:17, DNA which encodes SEQ ID NO:18, DNA which encodes SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, DNA which encodes a pesticidal portion of SEQ ID NO:28, SEQ ID NO:37, DNA which encodes SEQ ID NO:38, SEQ ID NO:42, and DNA which encodes SEQ ID NO:43;

[0228] (b) said toxin immunoreacts with an antibody to an approximately 40-50 kDa pesticidal toxin, or a fragment thereof, from a Bacillus thuringiensis isolate selected from the group consisting of PS80JJ1 having the identifying characteristics of NRRL B-18679, PS149B1 having the identifying characteristics of NRRL B-21553, and PS167H2 having the identifying characteristics of NRRL B-21554;

[0229] (c) said toxin is encoded by a nucleotide sequence wherein a portion of said nucleotide sequence can be amplified by PCR using a primer pair selected from the group consisting of SEQ ID NOs:20 and 24 to produce a fragment of about 495 bp, SEQ ID NOs:20 and 25 to produce a fragment of about 594 bp, SEQ ID NOs:21 and 24 to produce a fragment of about 471 bp, and SEQ ID NOs:21 and 25 to produce a fragment of about 580 bp;

[0230] (d) said toxin comprises a pesticidal portion of the amino acid sequence shown in SEQ ID NO:28;

[0231] (e) said toxin comprises an amino acid sequence which has at least about 60% homology with a pesticidal portion of an amino acid sequence selected from the group consisting of SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:38, and SEQ ID NO:43;

[0232] (f) said toxin is encoded by a nucleotide sequence which hybridizes under stringent conditions with a nucleotide sequence selected from the group consisting of DNA which encodes SEQ ID NO:3, DNA which encodes SEQ ID NO:5, DNA which encodes SEQ ID NO:7, DNA which encodes SEQ ID NO:32, DNA which encodes SEQ ID NO:36, and DNA which encodes SEQ ID NO:41;

[0233] (g) said toxin immunoreacts with an antibody to an approximately 10-15 kDa pesticidal toxin, or a fragment thereof, from a Bacillus thuringiensis isolate selected from the group consisting of PS80JJ1 having the identifying characteristics of NRRL B-18679, PS149B1 having the identifying characteristics of NRRL B-21553, and PS167H2 having the identifying characteristics of NRRL B-21554;

[0234] (h) said toxin is encoded by a nucleotide sequence wherein a portion of said nucleotide sequence can be amplified by PCR using the primer pair of SEQ ID NO:29 and SEQ ID NO:33; and

[0235] (i) said toxin comprises an amino acid sequence which has at least about 60% homology with an amino acid sequence selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, pesticidal portions of SEQ ID NO:32, pesticidal portions of SEQ ID NO:36, and pesticidal portions of SEQ ID NO:41.

[0236] Modification of genes and toxins. The genes and toxins useful according to the subject invention include not only the specifically exemplified full-length sequences, but also portions and/or fragments (including internal and/or terminal deletions compared to the full-length molecules) of these sequences, variants, mutants, chimerics, and fusions thereof. Proteins of the subject invention can have substituted amino acids so long as they retain the characteristic pesticidal activity of the proteins specifically exemplified herein. “Variant” genes have nucleotide sequences which encode the same toxins or which encode toxins having pesticidal activity equivalent to an exemplified protein. As used herein, the term “equivalent toxins” refers to toxins having the same or essentially the same biological activity against the target pests as the exemplified toxins. As used herein, reference to “essentially the same” sequence refers to sequences which have amino acid substitutions, deletions, additions, or insertions which do not materially affect pesticidal activity. Fragments retaining pesticidal activity are also included in this definition. Fragments and equivalents which retain the pesticidal activity of the exemplified toxins would be within the scope of the subject invention.

[0237] Equivalent toxins and/or genes encoding these equivalent toxins can be derived from wild-type or recombinant B.t. isolates and/or from other wild-type or recombinant organisms using the teachings provided herein. Other Bacillus species, for example, can be used as source isolates.

[0238] Variations of genes may be readily constructed using standard techniques for making point mutations, for example. Also, U.S. Pat. No. 5,605,793, for example, describes methods for generating additional molecular diversity by using DNA reassembly after random fragmentation. Variant genes can be used to produce variant proteins; recombinant hosts can be used to produce the variant proteins. Fragments of full-length genes can be made using commercially available exonucleases or endonucleases according to standard procedures. For example, enzymes such as Bal31 or site-directed mutagenesis can be used to systematically cut off nucleotides from the ends of these genes. Also, genes which encode active fragments may be obtained using a variety of restriction enzymes. Proteases may be used to directly obtain active fragments of these toxins.

[0239] There are a number of methods for obtaining the pesticidal toxins of the instant invention. For example, antibodies to the pesticidal toxins disclosed and claimed herein can be used to identify and isolate other toxins from a mixture of proteins. Specifically, antibodies may be raised to the portions of the toxins which are most constant and most distinct from other B.t. toxins. These antibodies can then be used to specifically identify equivalent toxins with the characteristic activity by immunoprecipitation, enzyme linked immunosorbent assay (ELISA), or western blotting. Antibodies to the toxins disclosed herein, or to equivalent toxins, or to fragments of these toxins, can readily be prepared using standard procedures. The genes which encode these toxins can then be obtained from the source microorganism.

[0240] Because of the redundancy of the genetic code, a variety of different DNA sequences can encode the amino acid sequences disclosed herein. It is well within the skill of a person trained in the art to create these alternative DNA sequences encoding the same, or essentially the same, toxins. These variant DNA sequences are within the scope of the subject invention.

[0241] Certain toxins of the subject invention have been specifically exemplified herein. Since these toxins are merely exemplary of the toxins of the subject invention, it should be readily apparent that the subject invention comprises variant or equivalent toxins (and nucleotide sequences coding for equivalent toxins) having the same or similar pesticidal activity of the exemplified toxin. Equivalent toxins will have amino acid similarity (and/or homology) with an exemplified toxin. The amino acid identity will typically be greater than 60%, preferably greater than 75%, more preferably greater than 80%, even more preferably greater than 90%, and can be greater than 95%. Preferred polynucleotides and proteins of the subject invention can also be defined in terms of more particular identity and/or similarity ranges. For example, the identity and/or similarity can be 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99% as compared to a sequence exemplified herein. Unless otherwise specified, as used herein percent sequence identity and/or similarity of two nucleic acids is determined using the algorithm of Karlin and Altschul (1990), Proc. Natl. Acad. Sci. USA 87:2264-2268, modified as in Karlin and Altschul (1993), Proc. Natl. Acad. Sci. USA 90:5873-5877. Such an algorithm is incorporated into the NBLAST and XBLAST programs of Altschul et al. (1990), J. Mol. Biol. 215:402-410. BLAST nucleotide searches are performed with the NBLAST program, score=100, wordlength=12, to obtain nucleotide sequences with the desired percent sequence identity. To obtain gapped aligrnents for comparison purposes, Gapped BLAST is used as described in Altschul et al. (1997), Nucl. Acids Res. 25:3389-3402. When utilizing BLAST and Gapped BLAST programs, the default parameters of the respective programs (NBLAST and XBLAST) are used. See http://www.ncbi.nih.gov. The scores can also be calculated using the methods and algorithms of Crickmore et al. as described in the Background section, above.

[0242] The amino acid homology will be highest in critical regions of the toxin which account for biological activity or are involved in the determination of three-dimensional configuration which ultimately is responsible for the biological activity. In this regard, certain amino acid substitutions are acceptable and can be expected if these substitutions are in regions which are not critical to activity or are conservative amino acid substitutions which do not affect the three-dimensional configuration of the molecule. For example, amino acids may be placed in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an amino acid of one class is replaced with another amino acid of the same type fall within the scope of the subject invention so long as the substitution does not materially alter the biological activity of the compound. Table 2 provides a listing of examples of amino acids belonging to each class.

TABLE 2
Class of Amino Acid Examples of Amino Acids
Nonpolar            Ala, Val, Leu, Ile, Pro, Met, Phe, Trp
Uncharged Polar     Gly, Ser, Thr, Cys, Tyr, Asn, Gln
Acidic              Asp, Glu
Basic               Lys, Arg, His

[0243] In some instances, non-conservative substitutions can also be made. The critical factor is that these substitutions must not significantly detract from the biological activity of the toxin.

[0244] As used herein, reference to “isolated” polynucleotides and/or “purified” toxins refers to these molecules when they are not associated with the other molecules with which they would be found in nature; these terms would include their use in plants. Thus, reference to “isolated” and/or “purified” signifies the involvement of the “hand of man” as described herein.

[0245] Synthetic genes which are functionally equivalent to the toxins of the subject invention can also be used to transform hosts. Methods for the production of synthetic genes can be found in, for example, U.S. Pat. No. 5,380,831.

[0246] Transgenic hosts. The toxin-encoding genes of the subject invention can be introduced into a wide variety of microbial or plant hosts. In preferred embodiments, expression of the toxin gene results, directly or indirectly, in the intracellular production and maintenance of the pesticide proteins. When transgenic/recombinant/transformed host cells are ingested by the pests, the pests will ingest the toxin. This is the preferred manner in which to cause contact of the pest with the toxin. The result is a control (killing or making sick) of the pest. Alternatively, suitable microbial hosts, e.g., Pseudomonas such as P. fluorescens, can be applied to the situs of the pest, where some of which can proliferate, and are ingested by the target pests. The microbe hosting the toxin gene can be treated under conditions that prolong the activity of the toxin and stabilize the cell. The treated cell, which retains the toxic activity, then can be applied to the environment of the target pest.

[0247] In preferred embodiments, recombinant plant cells and plants are used. Preferred plants (and plant cells) are corn and/or maize.

[0248] Where the B.t. toxin gene is introduced via a suitable vector into a microbial host, and said host is applied to the environment in a living state, certain host microbes should be used. Microorganism hosts are selected which are known to occupy the “phytosphere” (phylloplane, phyllosphere, rhizosphere, and/or rhizoplane) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment (crop and other insect habitats) with the wild-type microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation.

[0249] A large number of microorganisms are known to inhabit the phylloplane (the surface of the plant leaves) and/or the rhizosphere (the soil surrounding plant roots) of a wide variety of important crops. These microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g., genera Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes; fungi, particularly yeast, e.g., genera Saccharomyces, Cryptococcus, Kluyveromyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacterium tumefaciens, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus, and Azotobacter vinlandii; and phytosphere yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffluens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Sporobolomyces roseus, S. odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms.

[0250] A wide variety of ways are available for introducing a B.t. gene encoding a toxin into the target host under conditions which allow for stable maintenance and expression of the gene. These methods are well known to those skilled in the art and are described, for example, in U.S. Pat. No. 5,135,867, which is incorporated herein by reference.

[0251] Treatment of cells. As mentioned above, B.t. or recombinant cells expressing a B.t. toxin can be treated to prolong the toxin activity and stabilize the cell. The pesticide microcapsule that is formed comprises the B.t. toxin within a cellular structure that has been stabilized and will protect the toxin when the microcapsule is applied to the environment of the target pest. Suitable host cells may include either prokaryotes or eukaryotes, normally being limited to those cells which do not produce substances toxic to higher organisms, such as mammals. However, organisms which produce substances toxic to higher organisms could be used, where the toxic substances are unstable or the level of application sufficiently low as to avoid any possibility of toxicity to a mammalian host. As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi.

[0252] The cell will usually be intact and be substantially in the proliferative form when treated, rather than in a spore form, although in some instances spores may be employed.

[0253] Treatment of the microbial cell, e.g., a microbe containing the B.t. toxin gene, can be by chemical or physical means, or by a combination of chemical and/or physical means, so long as the technique does not deleteriously affect the properties of the toxin, nor diminish the cellular capability of protecting the toxin. Examples of chemical reagents are halogenating agents, particularly halogens of atomic no. 17-80. More particularly, iodine can be used under mild conditions and for sufficient time to achieve the desired results. Other suitable techniques include treatment with aldehydes, such as glutaraldehyde; anti-infectives, such as zephiran chloride and cetylpyridinium chloride; alcohols, such as isopropyl and ethanol; various histologic fixatives, such as Lugol iodine, Bouin's fixative, various acids and Helly's fixative (See: Humason, Gretchen L., Animal Tissue Techniques, W.H. Freeman and Company, 1967); or a combination of physical (heat) and chemical agents that preserve and prolong the activity of the toxin produced in the cell when the cell is administered to the host environment. Examples of physical means are short wavelength radiation such as gamma-radiation and X-radiation, freezing, UV irradiation, lyophilization, and the like. Methods for treatment of microbial cells are disclosed in U.S. Pat. Nos. 4,695,455 and 4,695,462, which are incorporated herein by reference.

[0254] The cells generally will have enhanced structural stability which will enhance resistance to environmental conditions. Where the pesticide is in a proform, the method of cell treatment should be selected so as not to inhibit processing of the proform to the mature form of the pesticide by the target pest pathogen. For example, formaldehyde will crosslink proteins and could inhibit processing of the proform of a polypeptide pesticide. The method of treatment should retain at least a substantial portion of the bio-availability or bioactivity of the toxin.

[0255] Characteristics of particular interest in selecting a host cell for purposes of production include ease of introducing the B.t. gene into the host, availability of expression systems, efficiency of expression, stability of the pesticide in the host, and the presence of auxiliary genetic capabilities. Characteristics of interest for use as a pesticide microcapsule include protective qualities for the pesticide, such as thick cell walls, pigmentation, and intracellular packaging or formation of inclusion bodies; survival in aqueous environments; lack of mammalian toxicity; attractiveness to pests for ingestion; ease of killing and fixing without damage to the toxin; and the like. Other considerations include ease of formulation and handling, economics, storage stability, and the like.

[0256] Growth of cells. The cellular host containing the B.t. insecticidal gene may be grown in any convenient nutrient medium, preferably where the DNA construct provides a selective advantage, providing for a selective medium so that substantially all or all of the cells retain the B.t. gene. These cells may then be harvested in accordance with conventional ways. Alternatively, the cells can be treated prior to harvesting.

[0257] The B.t. cells of the invention can be cultured using standard art media and fermentation techniques. Upon completion of the fermentation cycle the bacteria can be harvested by first separating the B.t. spores and crystals from the fermentation broth by means well known in the art. The recovered B.t. spores and crystals can be formulated into a wettable powder, liquid concentrate, granules or other formulations by the addition of surfactants, dispersants, inert carriers, and other components to facilitate handling and application for particular target pests. These formulations and application procedures are all well known in the art.

[0258] Formulations. Formulated bait granules containing an attractant and spores and crystals of the B.t. isolates, or recombinant microbes comprising the genes obtainable from the B.t. isolates disclosed herein, can be applied to the soil. Formulated product can also be applied as a seed-coating or root treatment or total plant treatment at later stages of the crop cycle. Plant and soil treatments of B.t. cells may be employed as wettable powders, granules or dusts, by mixing with various inert materials, such as inorganic minerals (phyllosilicates, carbonates, sulfates, phosphates, and the like) or botanical materials (powdered corncobs, rice hulls, walnut shells, and the like). The formulations may include spreader-sticker adjuvants, stabilizing agents, other pesticidal additives, or surfactants. Liquid formulations may be aqueous-based or non-aqueous and employed as foams, gels, suspensions, emulsifiable concentrates, or the like. The ingredients may include rheological agents, surfactants, emulsifiers, dispersants, or polymers.

[0259] As would be appreciated by a person skilled in the art, the pesticidal concentration will vary widely depending upon the nature of the particular formulation, particularly whether it is a concentrate or to be used directly. The pesticide will be present in at least 1% by weight and may be 100% by weight. The dry formulations will have from about 1-95% by weight of the pesticide while the liquid formulations will generally be from about 1-60% by weight of the solids in the liquid phase. The formulations will generally have from about 102 to about 104 cells/mg. These formulations will be administered at about 50 mg (liquid or dry) to 1 kg or more per hectare.

[0260] The formulations can be applied to the environment of the pest, e.g., soil and foliage, by spraying, dusting, sprinkling, or the like.

[0261] Mutants. Mutants of the isolates of the invention can be made by procedures well known in the art. For example, an asporogenous mutant can be obtained through ethylmethane sulfonate (EMS) mutagenesis of an isolate. The mutants can be made using ultraviolet light and nitrosoguanidine by procedures well known in the art.

[0262] A smaller percentage of the asporogenous mutants will remain intact and not lyse for extended fermentation periods; these strains are designated lysis minus (−). Lysis minus strains can be identified by screening asporogenous mutants in shake flask media and selecting those mutants that are still intact and contain toxin crystals at the end of the fermentation. Lysis minus strains are suitable for a cell treatment process that will yield a protected, encapsulated toxin protein.

[0263] To prepare a phage resistant variant of said asporogenous mutant, an aliquot of the phage lysate is spread onto nutrient agar and allowed to dry. An aliquot of the phage sensitive bacterial strain is then plated directly over the dried lysate and allowed to dry. The plates are incubated at 30° C. The plates are incubated for 2 days and, at that time, numerous colonies could be seen growing on the agar. Some of these colonies are picked and subcultured onto nutrient agar plates. These apparent resistant cultures are tested for resistance by cross streaking with the phage lysate. A line of the phage lysate is streaked on the plate and allowed to dry. The presumptive resistant cultures are then streaked across the phage line. Resistant bacterial cultures show no lysis anywhere in the streak across the phage line after overnight incubation at 30° C. The resistance to phage is then reconfirmed by plating a lawn of the resistant culture onto a nutrient agar plate. The sensitive strain is also plated in the same manner to serve as the positive control. After drying, a drop of the phage lysate is placed in the center of the plate and allowed to dry. Resistant cultures showed no lysis in the area where the phage lysate has been placed after incubation at 30° C. for 24 hours.

[0264] Following are examples which illustrate procedures for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.

Example 1

Culturinz of B.t. Isolates of the Invention

[0265] A subculture of the B.t. isolates, or mutants thereof, can be used to inoculate the following medium, a peptone, glucose, salts medium.

Bacto Peptone  7.5 g/l
Glucose        1.0 g/l
KH2PO4         3.4 g/l
K2HPO4         4.35 g/l
Salt Solution  5.0 ml/l
CaCl2 Solution 5.0 ml/l
pH             7.2

[0266] Salts Solution (100 ml)

MgSO4.7H2O 2.46 g
MnSO4.H2O  0.04 g
ZnSO4.7H2O 0.28 g
FeSO4.7H2O 0.40 g

[0267] CaCl2 Solution (100 ml)

CaCl2.2H2O 3.66 g

[0268] The salts solution and CaCl2 solution are filter-sterilized and added to the autoclaved and cooked broth at the time of inoculation. Flasks are incubated at 30° C. on a rotary shaker at 200 rpm for 64 hr.

[0269] The above procedure can be readily scaled up to large fermentors by procedures well known in the art.

[0270] The B.t. spores and/or crystals, obtained in the above fermentation, can be isolated by procedures well known in the art. A frequently-used procedure is to subject the harvested fermentation broth to separation techniques, e.g., centrifugation.

Example 2

Activity of Sporulated Bacillus thuringiensis Cultures on Corn Rootworm

[0271] Liquid cultures of PS80JJ1, PS149B1 or PS167H2 were grown to sporulation in shake flasks and pelleted by centrifugation. Culture pellets were resuspended in water and assayed for activity against corn rootworm in top load bioassays as described above. The amounts of 14 kDa and 44.3 kDa proteins present in the culture pellets were estimated by densitometry and used to calculate specific activity expressed as LC50. Activity of each native B. thuringiensis strain is presented in Table 3 (WCRW top load bioassay of B.t. strains).

TABLE 3
WCRW Top Load Bioassay of B.t. Strains
	B.t. strain	LC50 (μg/cm2)*	95% CL	Slope
	PS80JJ1	6	4-8	1.5
	PS167H2	6	4-9	1.6
	PS149B1	8	4-12	1.8
	CryB cell blank	4%	N/A	N/A
	Water blank	4%	N/A	N/A
	*Percentage mortality at top dose is provided for controls

Example 3

Protein Purification for 45 kDa 80JJ1 Protein

[0272] One gram of lyophilized powder of 80JJ 1 was suspended in 40 ml of buffer containing 80 mM Tris-Cl pH 7.8, 5 mM EDTA, 100 μM PMSF, 0.5 μg/ml Leupeptin, 0.7. μg/ml Pepstatin, and 40 μg/ml Bestatin. The suspension was centrifuged, and the resulting supernatant was discarded. The pellet was washed five times using 35-40 ml of the above buffer for each wash. The washed pellet was resuspended in 10 ml of 40% NaBr, 5 mM EDTA, 100 μM PMSF, 0.5 μg/ml Leupeptin, 0.7 μg/ml Pepstatin, and 40 μg/ml Bestatin and placed on a rocker platform for 75 minutes. The NaBr suspension was centrifuged, the supernatant was removed, and the pellet was treated a second time with 40% NaBr, 5 mM EDTA, 100 μM PMSF, 0.5 μg/ml Leupeptin, 0.7 μg/ml Pepstatin, and 40 μg/ml Bestatin as above. The supernatants (40% NaBr soluble) were combined and dialyzed against 10 mM CAPS pH 10.0, 1 mM EDTA at 4° C. The dialyzed extracts were centrifuged and the resulting supernatant was removed. The pellet (40% NaBr dialysis pellet) was suspended in 5 ml of H2O and centrifuged. The resultant supernatant was removed and discarded. The washed pellet was washed a second time in 10 ml of H2O and centrifuged as above. The washed pellet was suspended in 1.5 ml of H2O and contained primarily three protein bands with apparent mobilities of approximately 47 kDa, 45 kDa, and 15 kDa when analyzed using SDS-PAGE. At this stage of purification, the suspended 40% NaBr dialysis pellet contained approximately 21 mg/ml of protein by Lowry assay.

[0273] The proteins in the pellet suspension were separated using SDS-PAGE (Laemlli, U.K. [1970] Nature 227:680) in 15% acrylamide gels. The separated proteins were then electrophoretically blotted to a PVDF membrane (Millipore Corp.) in 10 mM CAPS pH 11.0, 10% MeOH at 100 V constant. After one hour the PVDF membrane was rinsed in water briefly and placed for 3 minutes in 0.25% Coomassie blue R-250, 50% methanol, 5% acetic acid. The stained membrane was destained in 40% MeOH, 5% acetic acid. The destained membrane was air-dried at room temperature (LeGendre et al. [1989] In A Practical Guide to Protein Purification For Microsequencing, P. Matsudaira, ed., Academic Press, New York, N.Y.). The membrane was sequenced using automated gas phase Edman degradation (Hunkapillar, M. W., R. M. Hewick, W. L. Dreyer, L. E. Hood [1983] Meth. Enzymol. 91:399).

[0274] The amino acid analysis revealed that the N-terminal sequence of the 45 kDa band was as follows: Met-Leu-Asp-Thr-Asn (SEQ ID NO:1).

[0275] The 47 kDa band was also analyzed and the N-terminal amino acid sequence was determined to be the same 5-amino acid sequence as SEQ ID NO:1. Therefore, the N-terminal amino acid sequences of the 47 kDa peptide and the 45 kDa peptide were identical.

[0276] This amino acid sequence also corresponds to a sequence obtained from a 45 kDa peptide obtained from PS80JJ1 spore/crystal powders, using another purification protocol, with the N-terminal sequence as follows: Met-Leu-Asp-Thr-Asn-Lys-Val-Tyr-Glu-Ile-Ser-Asn-Leu-Ala-Asn-Gly-Leu-Tyr-Thr-Ser-Thr-Tyr-Leu-Ser-Leu (SEQ ID NO:2).

Example 4

Purification of the 14 kDa Peptide of PS80JJ1

[0277] 0.8 ml of the white dialysis suspension (approximately 21 mg/ml) containing the 47 kDa, 45 kDa, and 15 kDa peptides, was dissolved in 10 ml of 40% NaBr, and 0.5 ml of 100 mM EDTA were added. After about 18 hours (overnight), a white opaque suspension was obtained. This was collected by centrifugation and discarded. The supernatant was concentrated in a Centricon-30 (Amicon Corporation) to a final volume of approximately 15 ml. The filtered volume was washed with water by filter dialysis and incubated on ice, eventually forming a milky white suspension. The suspension was centrifuged and the pellet and supernatant were separated and retained. The pellet was then suspended in 1.0 ml water (approximately 6 mg/ml). The pellet contained substantially pure 15 kDa protein when analyzed by SDS-PAGE.

[0278] The N-terminal amino acid sequence was determined to be: Ser-Ala-Arg-Glu-Val-His-Ile-Glu-Ile-Asn-Asn-Thr-Arg-His-Thr-Leu-Gln-Leu-Glu-Ala-Lys-Thr-Lys-Leu (SEQ ID NO:3).

Example 5

Bioassay of Protein

[0279] A preparation of the insoluble fraction from the dialyzed NaBr extract of 80JJ1 containing the 47 kDa, 45 kDa, and 15 kDa peptides was bioassayed against Western corn rootworm and were found to exhibit significant toxin activity.

Example 6

Protein Purification and Characterization of PS149B1 45 kDa Protein

[0280] The P1 pellet was resuspended with two volumes of deionized water per unit wet weight, and to this was added nine volumes of 40% (w/w) aqueous sodium bromide. This and all subsequent operations were carried out on ice or at 4-6° C. After 30 minutes, the suspension was diluted with 36 volumes of chilled water and centrifuged at 25,000×g for 30 minutes to give a pellet and a supernatant.

[0281] The resulting pellet was resuspended in 1-2 volumes of water and layered on a 20-40% (w/w) sodium bromide gradient and centrifuged at 8,000×g for 100 minutes. The layer banding at approximately 32% (w/w) sodium bromide (the “inclusions”, or INC) was recovered and dialyzed overnight against water using a dialysis membrane with a 6-8 kDa MW cut-off. Particulate material was recovered by centrifugation at 25,000×g, resuspended in water, and aliquoted and assayed for protein by the method of Lowry and by SDS-PAGE.

[0282] The resulting supernatant was concentrated 3- to 4-fold using Centricon-10 concentrators, then dialyzed overnight against water using a dialysis membrane with a 6-8 kDa MW cut-off. Particulate material was recovered by centrifugation at 25,000×g, resuspended in water, and aliquoted and assayed for protein by the method of Lowry and by SDS-PAGE. This fraction was denoted as P1.P2.

[0283] The peptides in the pellet suspension were separated using SDS-PAGE (Laemlli, U.K., supra) in 15% acrylamide gels. The separated proteins were then electrophoretically blotted to a PVDF membrane (Millipore Corp.) in 10 mM CAPS pH 11.0, 10% MeOH at 100 V constant. After one hour the PVDF membrane was rinsed in water briefly and placed for 3 minutes in 0.25% Coomassie blue R-250, 50% methanol, 5% acetic acid. The stained membrane was destained in 40% MeOH, 5% acetic acid. The destained membrane was air-dried at room temperature (LeGendre et al., supra). The membrane was sequenced using automated gas phase Edman degradation (Hunkapillar et al., supra).

[0284] Protein analysis indicated the presence of two major polypeptides, with molecular weights of 47 kDa and 14 kDa. Molecular weights were measured against standard polypeptides of known molecular weight. This process provides only an estimate of true molecular weight. The 47 kDa band from PS149B1 migrated on SDS-PAGE in a manner indistinguishable from the 47 kDa protein from PS80 μl. Likewise, the 14 kDa band from PS149B1 migrated on SDS-PAGE in a manner indistinguishable from 14 kDa bands from PS167H2 and PS80JJ1. Apart from these two polypeptides, which were estimated to account for 25-35% (47 kDa) and 35-55% (15 kDa) of the Coomassie staining material respectively, there may be minor bands, including those of estimated MW at 46 kDa, 130 kDa, and 70 kDa.

[0285] Protein analysis indicated that fraction INC contained a single polypeptide with MW of 47 kDa, and that fraction P1.P2 contained a single polypeptide with MW of 14 kDa. These polypeptides were recovered in yields greater than 50% from P1.

[0286] The N-terminal amino acid sequence for the purified 47 kDa protein from PS149B1 is: Met-Leu-Asp-Thr-Asn-Lys-Val-Tyr-Glu-Ile-Ser-Asn-His-Ala-Asn-Gly-Leu-Tyr-Ala-Ala-Thr-Tyr-Leu-Ser-Leu (SEQ ID NO:4).

[0287] The N-terminal amino acid sequence for the purified 14 kDa protein from PS149B1 is: Ser-Ala-Arg-Glu-Val-His-Ile-Asp-Val-Asn-Asn-Lys-Thr-Gly-His-Thr-Leu-Gln-Leu-Glu-Asp-Lys-Thr-Lys-Leu-Asp-Gly-Gly-Arg-Trp-Arg-Thr-Ser-Pro-Xaa-Asn-Val-Ala-Asn-Asp-Gln-Ile-Lys-Thr-Phe-Val-Ala-Glu-Ser-Asn (SEQ ID NO:5).

Example 7

Amino Acid Sequence for 45 kDa and 14 kDa Toxins of PS167H2

[0288] The N-terminal amino acid sequence for the purified 45 kDa protein from PS167H2 is: Met-Leu-Asp-Thr-Asn-Lys-Ile-Tyr-Glu-Ile-Ser-Asn-Tyr-Ala-Asn-Gly-Leu-His-Ala-Ala-Thr-Tyr-Leu-Ser-Leu (SEQ ID NO:6).

[0289] The N-terminal amino acid sequence for the purified 14 kDa protein from PS167H2 is: Ser-Ala-Arg-Glu-Val-His-Ile-Asp-Val-Asn-Asn-Lys-Thr-Gly-His-Thr-Leu-Gln-Leu-Glu-Asp-Lys-Thr-Lys-Leu (SEQ ID NO:7).

[0290] These amino acid sequences can be compared to the sequence obtained for the 47 kDa peptide obtained from 80JJ1 spore/crystal powders with the N-terminal sequence (SEQ ID NO:1) and to the sequence obtained for the 14 kDa peptide obtained from 80JJ1 spore/crystal powders with the N-terminal sequence (SEQ ID NO:3).

[0291] Clearly, the 45-47 kDa proteins are highly related, and the 14 kDa proteins are highly related.

Example 8

Bioassay of Protein

[0292] The purified protein fractions from PS149B1 were bioassayed against western corn rootworm and found to exhibit significant toxin activity when combined. In fact, the combination restored activity to that noted in the original preparation (P1). The following bioassay data set presents percent mortality and demonstrates this effect.

TABLE 4
Concentration (μg/cm2)	P1	INC	P1 · P2	INC + P1 · P2
300	88, 100, 94	19	13	100
100	94, 50, 63	31	38	94
33.3	19, 19, 44	38	13	50
11.1	13, 56, 25	12	31	13
3.7	0, 50, 0	0	31	13
1.2	13, 43, 12	0	12	19
0.4	6, 12, 6	25	19	6

Example 9

Molecular Cloning, Expression, and DNA Sequence Analysis of a Novel 6-Endotoxin Gene from Bacillus thuringiensis Strain PS80JJ1

[0293] Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) cells grown to an optical density, at 600 nm, of 1.0. Cells were pelleted by centrifugation and resuspended in protoplast buffer (20 mg/ml lysozyme in 0.3 M sucrose, 25 mM Tris-Cl [pH 8.0], 25 mM EDTA). After incubation at 37° C. for 1 hour, protoplasts were lysed by two cycles of freezing and thawing. Nine volumes of a solution of 0.1 M NaCl, 0.1% SDS, 0.1 M Tris-Cl were added to complete lysis. The cleared lysate was extracted twice with phenol:chloroform (1:1). Nucleic acids were precipitated with two volumes of ethanol and pelleted by centrifugation. The pellet was resuspended in TE buffer and RNase was added to a final concentration of 50 μg/ml. After incubation at 37° C. for 1 hour, the solution was extracted once each with phenol:chloroform (1:1) and TE-saturated chloroform. DNA was precipitated from the aqueous phase by the addition of one-tenth volume of 3 M NaOAc and two volumes of ethanol. DNA was pelleted by centrifugation, washed with 70% ethanol, dried, and resuspended in TE buffer.

[0294] An oligonucleotide probe for the gene encoding the PS80JJ1 45 kDa toxin was designed from N-terminal peptide sequence data. The sequence of the 29-base oligonucleotide probe was:

[0295] 5′-ATG YTW GAT ACW AAT AAA GTW TAT GAA AT-3′ (SEQ ID NO:8)

[0296] This oligonucleotide was mixed at four positions as shown. This probe was radiolabeled with 32P and used in standard condition hybridization of Southern blots of PS80JJ1 total cellular DNA digested with various restriction endonucleases. Representative autoradiographic data from these experiments showing the sizes of DNA restriction fragments containing sequence homology to the 44.3 kDa toxin oligonucleotide probe of SEQ ID NO:8 are presented in Table 5.

TABLE 5
RFLP of PS80JJ1 cellular DNA fragments on Southern blots that
hybridized under standard conditions with the 44.3 kDa toxin gene
oligonucleotide probe (SEQ ID NO: 8)
Restriction Enzyme Approximate Fragment Size (kbp)
EcoRI              6.0
HindIII            8.3
KpnI               7.4
PstI               11.5
XbaI               9.1

[0297] These DNA fragments identified in these analyses contain all or a segment of the PS80JJ1 45 kDa toxin gene. The approximate sizes of the hybridizing DNA fragments in Table 5 are in reasonable agreement with the sizes of a subset of the PS80JJ1 fragments hybridizing with a PS80JJ1 45 kDa toxin subgene probe used in separate experiments, as predicted (see Table 6, below).

[0298] A gene library was constructed from PS80JJ1 DNA partially digested with Sau3AI. Partial restriction digests were fractionated by agarose gel electrophoresis. DNA fragments 9.3 to 23 kbp in size were excised from the gel, electroeluted from the gel slice, purified on an Elutip-D ion exchange column (Schleicher and Schuell, Keene, N. H.), and recovered by ethanol precipitation. The Sau3AI inserts were ligated into BamHI-digested LambdaGem-11 (Promega, Madison, Wis.). Recombinant phage were packaged and plated on E. coli KW251 cells. Plaques were screened by hybridization with the oligonucleotide probe described above. Hybridizing phage were plaque-purified and used to infect liquid cultures of E. coli KW251 cells for isolation of DNA by standard procedures (Maniatis et al., supra).

[0299] Southern blot analysis revealed that one of the recombinant phage isolates contained an approximately 4.8 kbp XbaI-SacI band that hybridized to the PS80JJ1 toxin gene probe. The SacI site flanking the PS80JJ1 toxin gene is a phage vector cloning site, while the flanking XbaI site is located within the PS80JJ1 DNA insert. This DNA restriction fragment was subcloned by standard methods into pBluescript S/K (Stratagene, San Diego, Calif.) for sequence analysis. The resultant plasmid was designated pMYC2421. The DNA insert was also subcloned into pHTBlueII (an E. coli/B. thuringiensis shuttle vector comprised of pBluescript S/K [Stratagene, La Jolla, Calif.] and the replication origin from a resident B.t. plasmid [D. Lereclus et al. (1989) FEMS Microbiology Letters 60:211-218]) to yield pMYC2420.

[0300] An oligonucleotide probe for the gene encoding the PS80JJ1 14 kDa toxin was designed from N-terminal peptide sequence data. The sequence of the 28-base oligonucleotide probe was: 5′ GW GAA GTW CAT ATW GAA ATW AAT AAT AC 3′ (SEQ ID NO:29). This oligonucleotide was mixed at four positions as shown. The probe was radiolabelled with 32P and used in standard condition hybridizations of Southern blots of PS80JJ1 total cellular and pMYC2421 DNA digested with various restriction endonucleases. These RFLP mapping experiments demonstrated that the gene encoding the 14 kDa toxin is located on the same genomic EcoRI fragment that contains the N-terminal coding sequence for the 44.3 kDa toxin.

[0301] To test expression of the PS80JJ1 toxin genes in B.t., pMYC2420 was transformed into the acrystalliferous (Cry-) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. Expression of both the approximately 14 and 44.3 kDa PS80JJ1 toxins encoded by pMYC2420 was demonstrated by SDS-PAGE analysis. Toxin crystal preparations from the recombinant CryB[pMYC2420] strain, MR536, were assayed and found to be active against western corn rootworm.

[0302] The PS80JJ1 toxin genes encoded by pMYC2421 were sequenced using the ABI373 automated sequencing system and associated software. The sequence of the entire genetic locus containing both open reading frames and flanking nucleotide sequences is shown in SEQ ID NO:30. The termination codon of the 14 kDa toxin gene is 121 base pairs upstream (5′) from the initiation codon of the 44.3 kDa toxin gene (FIG. 2). The PS80JJ1 14 kDa toxin open reading frame nucleotide sequence (SEQ ID NO:31), the 44.3 kDa toxin open reading frame nucleotide sequence (SEQ ID NO:10), and the respective deduced amino acid sequences (SEQ ID NO:32 and SEQ ID NO:11) are novel compared to other toxin genes encoding pesticidal proteins.

[0303] Thus, the nucleotide sequence encoding the 14 kDa toxin of PS80JJ1 is shown in SEQ ID NO:31. The deduced amino acid sequence of the 14 kDa toxin of PS80JJ1 is shown in SEQ ID NO:32. The nucleotide sequences encoding both the 14 and 45 kDa toxins of PS80JJ1, as well as the flanking sequences, are shown in SEQ ID NO:30. The relationship of these sequences is shown in FIG. 2.

[0304] A subculture of E. coli NM522 containing plasmid pMYC2421 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Mar. 28, 1996. The accession number is NRRL B-21555.

Example 10

RFLP and PCR Analysis of Additional Novel δ-Endotoxin Genes from Bacillus thuringiensis Strains PS149B1 and PS167H2

[0305] Two additional strains active against corn rootworm, PS149B1 and PS167H2, also produce parasporal protein crystals comprised in part of polypeptides approximately 14 and 45 kDa in size. Southern hybridization and partial DNA sequence analysis were used to examine the relatedness of these toxins to the 80JJ1 toxins. DNA was extracted from these B.t, strains as described above, and standard Southern hybridizations were performed using the 14 kDa toxin oligonucleotide probe (SEQ ID NO:29) and an approximately 800 bp PCR fragment of the 80JJ1 44.3 kDa toxin gene-encoding sequence. RFLP data from these experiments showing the sizes of DNA restriction fragments containing sequence homology to the 44.3 kDa toxin are presented in Table 6. RFLP data from these experiments showing the sizes of DNA restriction fragments containing sequence homology to the approximately 14 kDa toxin are presented in Table 7.

TABLE 6
RFLP of PS80JJ1, PS149B1, and PS167H2 cellular DNA
fragments on Southern blots that hybridized with the
approximately 800 bp PS80JJ1 44.3 kDa
toxin subgene probe under standard conditions
	Strain
		PS80JJ1	PS149B1	PS167H2
	Restriction enzyme	Approximate fragment size (kbp)
	EcoRI	6.4	5.7	2.6
		1.3	2.8
		0.6
	HindIII	8.2	6.2	4.4
	KpnI	7.8	10.0	11.5
	PstI	12.0	9.2	9.2
				8.2
	XbaI	9.4	10.9	10.9
	SacI	17.5	15.5	11.1
		13.1	10.5	6.3

[0306] Each of the three strains exhibited unique RFLP patterns. The hybridizing DNA fragments from PS149B1 or PS167H2 contain all or part of toxin genes with sequence homology to the PS80JJ1 44.3 kDa toxin.

TABLE 7
Restriction fragment length polymorphisms of PS80JJ1,
PS149B1, and PS167H2 cellular DNA fragments on
Southern blots that hybridized with the PS80JJ1 14 kDa
toxin oligonucleotide probe under standard conditions
	Strain
		PS80JJ1	PS149B1	PS167H2
	Restriction enzyme	Approximate fragment size (kbp)
	EcoRI	5.6	2.7	2.7
	HindIII	7.1	6.0	4.7
	XbaI	8.4	11.2	11.2

[0307] Each of the three strains exhibited unique RFLP patterns. The hybridizing DNA fragments from PS149B1 or PS167H2 contain all or part of toxin genes with sequence homology to the PS80JJ1 14 kDa toxin gene.

[0308] Portions of the toxin genes in PS149B1 or PS167H2 were amplified by PCR using forward and reverse oligonucleotide primer pairs designed based on the PS80JJ1 44.3 kDa toxin gene sequence. For PS149B1, the following primer pair was used:

Forward:
5′-ATG YTW GAT ACW AAT AAA GTW TAT GAA AT-3′ (SEQ ID NO:8)
Reverse:
5′-GGA TTA TCT ATC TCT GAG TGT TCT TG-3′ (SEQ ID NO:9)

[0309] For PS167H2, the same primer pair was used. These PCR-derived fragments were sequenced using the ABI373 automated sequencing system and associated software. The partial gene and peptide sequences obtained are shown in SEQ ID NO:12-15. These sequences contain portions of the nucleotide coding sequences and peptide sequences for novel corn rootworm-active toxins present in B.t. strains PS149B1 or PS167H2.

Example 11

Molecular Cloning and DNA Sequence Analysis of Novel δ-Endotoxin Genes from Bacillus thuringiensis Strains PS149B1 and PS167H2

[0310] Total cellular DNA was extracted from strains PS149B1 and PS167H2 as described for PS80JJ1. Gene libraries of size-fractionated Sau3A partial restriction fragments were constructed in Lambda-Gem11 for each respective strain as previously described. Recombinant phage were packaged and plated on E. coli KW251 cells. Plaques were screened by hybridization with the oligonucleotide probe specific for the 44 kDa toxin gene. Hybridizing phage were plaque-purified and used to infect liquid cultures of E. coli KW251 cells for isolation of DNA by standard procedures (Maniatis et al., supra).

[0311] For PS167H2, Southern blot analysis revealed that one of the recombinant phage isolates contained an approximately 4.0 to 4.4 kbp HindIII band that hybridized to the PS80JJ1 44 kDa toxin gene 5′ oligonucleotide probe (SEQ ID NO:8). This DNA restriction fragment was subcloned by standard methods into pBluescript S/K (Stratgene, San Diego, Calif.) for sequence analysis. The fragment was also subcloned into the high copy number shuttle vector, pHT370 (Arantes, O., D. Lereclus [1991] Gene 108:115-119) for expression analyses in Bacillus thuringiensis (see below). The resultant recombinant, high copy number bifunctional plasmid was designated pMYC2427.

[0312] The PS167H2 toxin genes encoded by pMYC2427 were sequenced using the ABI automated sequencing system and associated software. The sequence of the entire genetic locus containing both open reading frames and flanking nucleotide sequences is shown in SEQ ID NO:34. The termination codon of the 14 kDa toxin gene is 107 base pairs upstream (5′) from the initiation codon of the 44 kDa toxin gene. The PS167H2 14 kDa toxin coding sequence (SEQ ID NO:35), the 44 kDa toxin coding sequence (SEQ ID NO:37), and the respective deduced amino acid sequences, SEQ ID NO:36 and SEQ ID NO:38, are novel compared to other known toxin genes encoding pesticidal proteins. The toxin genes are arranged in a similar manner to, and have some homology with, the PS80JJ1 14 and 44 kDa toxins.

[0313] A subculture of E. coli NM522 containing plasmid pMYC2427 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on 26 Mar. 1997. The accession number is NRRL B-21672.

[0314] For PS149B1, Southern blot analysis using the PS80JJ1 44 kDa oligonucleotide 5′ probe (SEQ ID NO:8) demonstrated hybridization of an approximately 5.9 kbp ClaI DNA fragment. Complete ClaI digests of PS149B1 genomic DNA were size fractionated on agarose gels and cloned into pHTBlueII. The fragment was also subcloned into the high copy number shuttle vector, pHT370 (Arantes, O., D. Lereclus [1991] Gene 108:115-119) for expression analyses in Bacillus thuringiensis (see below). The resultant recombinant, high copy number bifunctional plasmid was designated pMYC2429.

[0315] The PS149B1 toxin genes encoded by pMYC2429 were sequenced using the ABI automated sequencing system and associated software. The sequence of the entire genetic locus containing both open reading frames and flanking nucleotide sequences is shown in SEQ ID NO:39. The termination codon of the 14 kDa toxin gene is 108 base pairs upstream (5′) from the initiation codon of the 44 kDa toxin gene. The PS149B1 14 kDa toxin coding sequence (SEQ ID NO:40), the 44 kDa toxin coding sequence (SEQ ID NO:42), and the respective deduced amino acid sequences, SEQ ID NO:41 and SEQ ID NO:43, are novel compared to other known toxin genes encoding pesticidal proteins. The toxin genes are arranged in a similar manner as, and have some homology with, the PS80JJ1 and PS167H214 and 44 kDa toxins. Together, these three toxin operons comprise a new family of pesticidal toxins.

[0316] A subculture of E. coli NM522 containing plasmid pMYC2429 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on 26 Mar. 1997. The accession number is NRRL B-21673.

Example 12

PCR Amplification for Identification and Cloning Novel Corn Rootworm-Active Toxin

[0317] The DNA and peptide sequences of the three novel approximately 45 kDa corn rootworm-active toxins from PS80JJ1, PS149B1, and PS167H2 (SEQ ID NOS.12-15) were aligned with the Genetics Computer Group sequence analysis program Pileup using a gap weight of 3.00 and a gap length weight of 0.10. The sequence alignments were used to identify conserved peptide sequences to which oligonucleotide primers were designed that were likely to hybridize to genes encoding members of this novel toxin family. Such primers can be used in PCR to amplify diagnostic DNA fragments for these and related toxin genes. Numerous primer designs to various sequences are possible, four of which are described here to provide an example. These peptide sequences are:

Asp-Ile-Asp-Asp-Tyr-Asn-Leu     (SEQ ID NO:16)
Trp-Phe-Leu-Phe-Pro-Ile-Asp     (SEQ ID NO:17)
Gln-Ile-Lys-Thr-Thr-Pro-Tyr-Tyr (SEQ ID NO:18)
Tyr-Glu-Trp-Gly-Thr-Glu.        (SEQ ID NO:19)

[0318] The corresponding nucleotide sequences are:

5′-GATATWGATGAYTAYAAYTTR-3′    (SEQ ID NO:20)
5′-TGGTTTTTRTTTCCWATWGAY-3′    (SEQ ID NO:21)
5′-CAAATHAAAACWACWCCATATTAT-3′ (SEQ ID NO:22)
5′-TAYGARTGGGGHACAGAA-3′.      (SEQ ID NO:23)

[0319] Forward primers for polymerase amplification in thermocycle reactions were designed based on the nucleotide sequences of SEQ ID NOs:20 and 21.

[0320] Reverse primers were designed based on the reverse complement of SEQ ID NOs:22 and 23:

5′-ATAATATGGWGTWGTTTTDATTTG-3′ (SEQ ID NO:24)
5′-TTCTGTDCCCCAYTCRTA-3′.      (SEQ ID NO:25)

[0321] These primers can be used in combination to amplify DNA fragments of the following sizes (Table 8) that identify genes encoding novel corn rootworm toxins.

TABLE 8
Predicted sizes of diagnostic DNA fragments
(base pairs) amplifiable with primers specific
for novel corn rootworm-active toxins
Primer pair (SEQ ID NO.) DNA fragment size (bp)
20 + 24                  495
20 + 25                  594
21 + 24                  471
21 + 25                  580

[0322] Similarly, entire genes encoding novel corn rootworm-active toxins can be isolated by polymerase amplification in thermocycle reactions using primers designed based on DNA sequences flanking the open reading frames. For the PS80JJ1 44.3 kDa toxin, one such primer pair was designed, synthesized, and used to amplify a diagnostic 1613 bp DNA fragment that included the entire toxin coding sequence. These primers are:

Forward:	5′-CTCAAAGCGGATCAGGAG-3′	(SEQ ID NO:26)
Reverse:	5′-GCGTATTCGGATATGCTTGG-3′.	(SEQ ID NO:27)

[0323] For PCR amplification of the PS80JJ1 14 kDa toxin, the oligonucleotide coding for the N-terminal peptide sequence (SEQ ID NO:29) can be used in combination with various reverse oligonucleotide primers based on the sequences in the PS80JJ1 toxin gene locus. One such reverse primer has the following sequence:

[0324] 5′CATGAGATTTATCTCCTGATCCGC 3′ (SEQ ID NO:33).

[0325] When used in standard PCR reactions, this primer pair amplified a diagnostic 1390 bp DNA fragment that includes the entire 14 kDa toxin coding sequence and some 3′ flanking sequences corresponding to the 121 base intergenic spacer and a portion of the 44.3 kDa toxin gene. When used in combination with the 14 kDa forward primer, PCR will generate a diagnostic 322 base pair DNA fragment.

Example 13

Clone Dose-Response Bioassays

[0326] The PS80J11 toxin operon was subcloned from pMYC2421 into pHT370 for direct comparison of bioactivity with the recombinant toxins cloned from PS149B1 and PS167H2. The resultant recombinant, high copy number bifunctional plasmid was designated pMYC2426.

[0327] A subculture of E. coli NM522 containing plasmid pMYC2426 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on 26 Mar. 1997. The accession number is NRRL B-21671.

[0328] To test expression of the PS80JJ1, PS149B1 and PS167H2 toxin genes in B.t., pMYC2426, pMYC2427 and pMYC2429 were separately transformed into the acrystalliferous (Cry-) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. The recombinant strains were designated MR543 (CryB [pMYC2426]), MR544 (CryB [pMYC2427]) and MR546 (CryB [pMYC2429]), respectively. Expression of both the approximately 14 and 44 kDa toxins was demonstrated by SDS-PAGE analysis for each recombinant strain.

[0329] Toxin crystal preparations from the recombinant strains were assayed against western corn rootworm. Their diet was amended with sorbic acid and SIGMA pen-strep-ampho-B. The material was top-loaded at a rate of 50 μl of suspension per cm2 diet surface area. Bioassays were run with neonate Western corn rootworm larvae for 4 days at approximately 25° C. Percentage mortality and top-load LC50 estimates for the clones (pellets) are set forth in Table 9. A dH2O control yielded 7% mortality.

	TABLE 9
	Percentage mortality at given
	protein concentration (μg/cm2)
	Sample	50 μg/cm2	5 μg/cm2	0.5 μg/cm2
	MR543 pellet	44%	19%	9%
	MR544 pellet	72%	32%	21%
	MR546 pellet	52%	32%	21%

[0330] The amounts of 14 kDa and 44.3 kDa proteins present in the crystal preparations were estimated by densitometry and used to calculate specific activity expressed as LC50. LC50 estimates for the clones (pellets) are set forth in Table 10 (WCRW top load bioassay of B.t. clones).

TABLE 10
WCRW Top Load Bioassay of B.t. Clones
	B.t.	B.t. Parental	LC50
	Clone	Strain	(μg/cm2)*	95% CL	Slope
	MR543	PS80JJ1	37	17-366*	0.79
	MR544	PS167H2	10	6-14	1.6
	MR546	PS149B1	8	4-12	1.5
	N/A	CryB cell blank	4%	N/A	N/A
	N/A	Water blank	4%	N/A	N/A
	*Percentage mortality at top dose is provided for controls
	**90% CL

Example 14

Mutational Analysis of the 14 and 44 kDa Polypeptides in the PS80JJ1 binary Toxin Operon

[0331] Binary toxin genes of the subject invention are, in their wild-type state, typically arranged in an operon wherein the 14 kDa protein gene is transcribed first, followed by that of the 45 kDa protein gene. These genes are separated by a relatively short, non-coding region. Representative ORFs are shown in SEQ ID NO:30, SEQ ID NO:34, and SEQ ID NO:39.

[0332] In order to investigate the contribution of the individual 14 and 44.3 kDa crystal proteins to corn rootworm activity, each gene in the PS80JJ1 operon was mutated in separate experiments to abolish expression of one of the proteins. The intact gene was then expressed in B.t. and recombinant proteins were tested for activity against corn rootworm.

[0333] First, the 44.3 kDa gene encoded on pMYC2421 was mutated by truncation at the EcoRI site at base position 387 of the open reading frame. This truncation and subsequent ligation with vector sequences resulted in an open reading frame encoding an approximately 24 kDa hypothetical fusion protein. The resulting operon encoding the intact 14 kDa gene and the truncated 45 kDa gene was subcloned into the high copy number shuttle vector, pHT370 (Arantes, O., D. Lereclus [1991] Gene 108:115-119) for expression analyses in Bacillus thuringiensis. The resulting plasmid, pMYC2424 was transformed into the acrystalliferous (Cry-) B.t. host, CryB (A. Aronson, Purdue University, West Lafayette, Ind.), by electroporation. The resulting recombinant strain was designated MR541. Only the 14 kDa PS80JJ1 protein was detectable by SDSPAGE analysis of sporulated cultures of MR541. Mortality was not observed for preparations of MR541 expressing only the 14 kDa PS80JJ1 protein in top-load bioassays against corn rootworm.

[0334] Next, the 14 kDa gene encoded on pMYC2421 was mutated by insertion of an oligonucleotide linker containing termination codons in all possible reading frames at the NruI site at base position 11 of the open reading frame. The sequence of this linker is 5′ TGAGTAACTAGATCTATTCAATTA 3′. The linker introduces a BglII site for confirmation of insertion by BglII restriction digestion. Plasmid clones containing the mutagenic linker were identified with BglII and sequenced for verification. The operon insert encoding the 14 kDa nonsense mutations was subcloned into pHT370, resulting in plasmid pMYC2425. This plasmid was transformed into CryB by electroporation to yield the recombinant B.t. strain MR542. Only the 44.3 kDa PS80JJ 1 protein was expressed in sporulated cultures of MR542 as shown by SDSPAGE analysis. Mortality against corn rootworm was not observed for preparations of MR542 expressing only the 44.3 kDa PS80JJ1 protein.

Example 15

Single Gene Heterologous Expression, Purification and Bioassay of the 14 and 44.3 kDa Polypeptides from PS149B1 in Pseudomonas Fluorescens

[0335] The 14 kDa and 44.3 kDa polypeptide genes from PS149B1 were separately engineered into plasmid vectors by standard DNA cloning methods, and transformed into Psuedomonas flourescens. The recombinant Pseudomonas fluorescens strain expressing only the PS149B1 14 kDa gene was designated MR1253. The recombinant Pseudomonas fluorescens strain expressing only the PS149B1 44.3 kDa gene was designated MR1256.

[0336] MR1253 and MR1256 each individually expressing one of the two binary proteins were grown in 1 L fermentation tanks. A portion of each culture was then pelleted by centrifugation, lysed with lysozyme, and treated with DNAse I to obtain semi-pure protein inclusions. These inclusions were then solubilized in 50 mM Sodium Citrate (pH 3.3) by gentle rocking at 4° C. for 1 hour. The 14 kDa protein dissolved readily in this buffer whereas the 44.3 kDa protein was partially soluble. The solubilized fractions were then centrifuged at 15,000×g for 20 minutes; and the supernatants were retained.

[0337] The 14 kDa protein was further purified through ion-exchange chromatography. The solubilized 14 kDa protein was bound to a Econo-S column and eluted with a Sodium Chloride 0-1M gradient.

[0338] The chromatographically pure MR1253 (14 kDa protein) and the Sodium Citrate (pH3.3) solubilized preparation of MR1256 (45 kDa protein) were then tested for activity on corn rootworm individually or together at a molar ratio of 1 to 10 (45 kDa protein to 14 kDa protein). Observed mortality for each of the proteins alone was not above background levels (of the water/control sample) but 87% mortality resulted when they were combined in the above ratio (see Table 11).

TABLE 11
Molar ratio	load	ug 45 kD/	ug 14 kD/	Total ug	CRW
(45 kD to 14 kD)	volume	well	well	protein	Mortality
0 to 1	100 ul	0	260	260	13
1 to 0	200 ul	260	0	260	9
1 to 10	100 ul	65	195	260	87
water	100 ul	0	0	0	11

Example 16

Identification of Additional Novel 14 kDa and 44.3 kDa Toxin Genes by Hybridization of Total B.t. Genomic DNA and by RFLP

[0339] Total genomic DNA from each isolate was prepared using the Qiagen DNEasy 96 well tissue kit. DNA in 96-well plates was denatured prior to blotting by adding 10 ul of each DNA sample and 10 ul of 4 M NaOH to 80 ul sterile distilled water. Samples were incubated at 70° C. for one hour after which 100 ul of 20×SSC was added to each well. PS149B1 total genomic DNA was included with each set of 94 samples as a positive hybridization control, and cryB- total genomic DNA was included with each set of 94 samples as a negative hybridization control. Each set of 96 samples was applied to Magnacharge nylon membranes using two 48 well slot blot manifolds (Hoefer Scientific), followed by two washes with 10×SSC. Membranes were baked at 80° C. for one hour and kept dry until used. Membranes were prehybridized and hybridized in standard formamide solution (50% formamide, 5×SSPE, 5× Denhardt's solution, 2% SDS, 100 ug/ml single stranded DNA) at 42° C. Membranes were washed under two conditions: 2×SSC/0.1% SDS at 42° C. (low stringency) and 0.2×SSC/0.1% SDS at 65° C. (moderate to high stringency). Membranes were probed with an approximately 1.3 kilobase pair PCR fragment of the PS149B1 44.3 kDa gene amplified from pMYC2429 using forward primer SEQ ID NO:8 and a reverse primer with the sequence 5′ GTAGAAGCAGAACAAGAAGGTATT 3′ (SEQ ID NO:46). The probe was radioactively labeled using the Prime-it II kit (Stratagene) and 32-P-dCTP, purified on Sephadex columns, denatured at 94° C. and added to fresh hybridization solution. Strains containing genes with homology to the PS149B1 probe were identified by exposing membranes to X-ray film.

[0340] The following strains were identified by positive hybridization reactions: PS184M2, PS185GG, PS187G1, PS187Y2, PS201G, PS201HH2, PS242K10, PS69Q, KB54A1-6, KR136, KR589, PS185L12, PS185W3, PS185Z11, PS186L9, PS187L14, PS186FF, PS131W2, PS147U2, PS158T3, PS158X10, PS185FF, PS187F3, PS198H3, PS201H2, PS201L3, PS203G2, PS203J1, PS204C3, PS204G4, PS204I11, PS204J7, PS210B, PS213E8, PS223L2, PS224F2, PS236B6, PS246P42, PS247C16, KR200, KR331, KR625, KR707, KR959, KR1209, KR1369, KB2C-4, KB10H-5, KB456, KB42C17-13, KB45A43-3, KB54A33-1, KB58A10−3, KB59A54-4, KB59A54-5, KB53B7-8, KB53B7-2, KB60F5-7, KB60F5-11, KB59A58-4, KB60F5-15, KB61A18-1, KB65A15-2, KB65A15-3, KB65A15-7, KB65A15-8, KB65A15-12, KB65A14-1, KB3F-3, T25, KB53A71-6, KB65A11-2, KB68B57-1, KB63A5-3, and KB71A118-6.

[0341] Further identification and classification of novel toxin genes in preparations of total genomic DNA was performed using the 32P-labeled probes and hybridization conditions described above in this Example. Total genomic DNA was prepared as above or with Qiagen Genomic-Tip 20/G and Genomic DNA Buffer Set according to protocol for Gram positive bacteria (Qiagen Inc.; Valencia, Calif.) was used in southern analysis. For Southern blots, approximately 1-2 μg of total genomic DNA from each strain identified by slot blot analysis was digested with Dral and NdeI enzymes, electrophoresed on a 0.8% agarose gel, and immobilized on a supported nylon membrane using standard methods (Maniatis et al.). After hybridization, membranes were washed under low stringency (2×SSC/0.1% SDS at 42° C.) and exposed to film. DNA fragment sizes were estimated using BioRad Chemidoc system software. Restriction fragment length polymorphisms were used to (arbitrarily) classify genes encoding the 44 kDa toxin. These classifications are set forth in Table 12.

TABLE 12
RFLP Class
(45 & 14 kD) Isolate Strain Name
A            149B1
A′           KR331, KR1209, KR1369
B            167H2, 242K10
C            184M2, 201G, 201HH2
D            185GG, 187Y2, 185FF1, 187F3
E            187G1
F            80JJ1, 186FF, 246P42
G            69Q
H            KB54A1-6
I            KR136
J            KR589
K            185L12, 185W3, 185Z11,
             186L9, 187L14
L            147U2, 210B, KB10H-5, KB58A10-3,
             KB59A54-4, KB59A54-5, KB59A58-4,
             KB65A14-1
M            158T3, 158X10
N            201H2, 201L3, 203G2, 203J1, 204C3, 204G4,
             204I11, 204J7, 236B6
P            223L2, 224F2
P′           247C16, KB45A43-3, KB53B7-8, KB53B7-2,
             KB61A18-1, KB3F-3, KB53A71-6, KB65A11-2,
             KB68B57-1, KB63A5-3, KB71A118-6
Q            213E8, KB60F5-11, KB60F5-15
R            KR959
S            KB2C-4, KB46, KB42C17-13
T            KB54A33-1, KB60F5-7
U            T25
V            KB65A15-2, KB65A15-3, KB65A15-7,
             KB65A15-8, KB65A15-12

Example 17

DNA sequencing of Additional Binary Toxin Genes

[0342] Degenerate oligonucleotides were designed to amplify all or part of the 14 and 44.3 kDa genes from B.t. strains identified by hybridization with the 149B1 PCR product described above. The oligonucleotides were designed to conserved sequence blocks identified by alignment of the 14 kDa or 44.3 kDa genes from PS149B1, PS167H2 and PS80JJ1. Forward primers for both genes were designed to begin at the ATG initiation codon. Reserve primers were designed as close to the 3′ end of each respective gene as possible.

[0343] The primers designed to amplify the 14 kDa gene are as follows:

149DEG1 (forward):	5′-ATG TCA GCW CGY GAA GTW CAY ATT G-3′	(SEQ ID NO:47)
149DEG2 (reverse):	5′-GTY TGA ATH GTA TAH GTH ACA TG-3′	(SEQ ID NO:48)

[0344] These primers amplify a product of approximately 340 base pairs.

[0345] The primers designed to amplify the 44.3 kDa gene are as follows:

149DEG3 (forward):	5′-ATG TTA GAT ACW AAT AAA RTW TAT G-3′	(SEQ ID NO:49)
149DEG4 (reverse):	5′-GTW ATT TCT TCW ACT TCT TCA TAH GAA G-3′	(SEQ ID NO:50)

[0346] These primers amplify a product of approximately 1,100 base pairs.

[0347] The PCR conditions used to amplify gene products are as follows:

[0348] 95° C., 1 min., one cycle

[0349] 95° C., 1 min.

[0350] 50° C., 2 min., this set repeated 35 cycles

[0351] 72° C., 2 min.

[0352] 72° C., 10 min., one cycle

[0353] PCR products were fractionated on 1% agarose gels and purified from the gel matrix using the Qiaexll kit (Qiagen). The resulting purified fragments were ligated into the pCR-TOPO cloning vector using the TOPO TA cloning kit (Invitrogen). After ligation, one half of the ligation reaction was transformed into XL10 Gold ultracompetant cells (Stratagene). Transformants were then screened by PCR with vector primers 1212 and 1233. Clones containing inserts were grown on the LB/carbenicillin medium for preparation of plasmids using the Qiagen plasmid DNA miniprep kit (Qiagen). Cloned PCR-derived fragments were then sequenced using Applied Biosystems automated sequencing systems and associated software. Sequences of additional novel binary toxin genes and polypeptides related to the holotype 14 and 44.3 kDa toxins from PS80JJ1 and PS149B1 are listed as SEQ ID NOS. 51-126. The section above, entitled “BriefDescription of the Sequences,” provides a further explanation of these sequences.

[0354] The 14 kDa-type toxins and genes from three additional B.t. strains, PS137A, PS201 V2 and PS207C3, were also sequenced using the above procedures (with any differences noted below). PCR using the 149DEG 1 (forward) and 149DEG2 (reverse) primers was performed. These primers amplify a product of approximately 340 base pairs. The PCR was performed with the following conditions:

[0355] 1. 95° C., 3 min.

[0356] 2. 94° C., 1 min.

[0357] 3. 42° C., 2 min.

[0358] 4. 72° C., 3 min.+5 sec./cycle

[0359] 5. Steps 2 through 4 repeated 29 times

[0360] PCR products were gel purified using the QiaQuick gel extraction kit (Qiagen), the purified fragment was ligated into the pCR-TOPO cloning vector using the TOPO-TA kit (Invitrogen), and subsequently transformed into XL10-Gold Ultracompetent E. coli cells (Strategene). Preparation of transformant DNA is described above. Sequences of the 14 kDa toxin gene for each of the three new strains were obtained as per above. The nucleotide and polypeptide sequences are provided in the attached Sequence Listing as follows: PS137A (SEQ ID NOs:149 and 150), PS201V2 (SEQ ID NOs:151 and 152), and PS207C3 (SEQ ID NOs:153 and 154).

Example 18

PS149B1 Toxin Transgenes and Plant Transformation

[0361] Separate synthetic transgenes optimized for maize codon usage were designed for both the 14 and 44.3 kDa toxin components. The synthetic versions were designed to modify the guanine and cytosine codon bias to a level more typical for plant DNA. Preferred plant-optimized transgenes are described in SEQ ID NOs: 127-128. The promoter region used for expression ofboth transgenes was the Zea mays ubiquitin promoter plus Z. mays exon 1 and Z. mays intron 1 (Christensen, A. H. et al. (1992) Plant Mol. Biol. 18:675-689). The transcriptional terminator used for both transgenes was the potato proteinase inhibitor II (PinII) terminator (An, G. et al. 1989 Plant Cell 1:115-22).

[0362] Phosphinothricin acetyltransferase (PAT) was used as the selectable marker for plant transformation. The phosphinothricin acetyltransferase gene (pat) was isolated from the bacterium Streptomyces viridochromogenes (Eckes P. et al., 1989). The PAT protein acetylates phosphinothricin, or its precursor demethylphosphinothricin, conferring tolerance to a chemically synthesized phosphinothricin such as the herbicide glufosinate-ammonium. Acetylation converts phosphinothricin to an inactive form that is no longer toxic to corn plants. Glufosinate ammonium is a broad spectrum, non-systemic, non-selective herbicide. Regenerating corn tissue or individual corn plants tolerant to glufosinate ammonium herbicide can be readily identified through incorporation of PAT into regeneration medium or by spray application of the herbicide to leaves.

[0363] The synthetic version of the pat gene was produced in order to modify the guanine and cytosine codon bias to a level more typical for plant DNA. The promoter for the pat gene is the CaMV promoter of the 35S transcript from cauliflower mosiac virus (Pietrzak et al., 1986). The transcriptional terminator is the CaMV 35 S terminator.

[0364] For transformation of maize tissue, a linear portion of DNA, containing both the PS149B 114 and 44.3 kDa andpat selectable marker coding sequences, and the regulatory components necessary for expression, was excised from a complete plasmid. This linear portion of DNA, termed an insert, was used in the transformation process.

[0365] Maize plants containing PS149B1 14 kDa and 44.3 kDa transgenes were obtained by microprojectile bombardment using the Biolistics®O PDS-100He particle gun manufactured by Bio-Rad, essentially as described by Klein et al. (1987). Immature embryos isolated from corn ears harvested approximately 15 days after pollination were cultured on callus initiation medium for three to eight days. On the day of transformation, microscopic tungsten particles were coated with purified DNA and accelerated into the cultured embryos, where the insert DNA was incorporated into the cell chromosome. Six days after bombardment, bombarded embryos were transferred to callus initiation medium containing glufosinate (Bialaphos) as the selection agent. Healthy, resistant callus tissue was obtained and repeatedly transferred to fresh selection medium for approximately 12 weeks. Plants were regenerated and transferred to the greenhouse. A total of 436 regenerated plants were obtained. Leaf samples were taken for molecular analysis to verify the presence of the transgenes by PCR and to confirm expression of the foreign protein by ELISA. Plants were then subjected to a whole plant bioassay using western corn rootworm. Positive plants were crossed with inbred lines to obtain seed from the initial transformed plants. These plants were found to be resistant to damage by corn rootworm in both greenhouse and field trials.

Example 19

Further Bioassays

[0366] Protein preparations from the strains identified on Example 16 were assayed for activity against western corn rootworm using the basic top load assay methods, as described in Example 13.

	TABLE 13
	Strain	LC50 (ug/cm2)	95% Cl
	KB45A43-3	9.48	6.58-15.27
	213‘E’8	10.24	7.50-19.87
	KR707	11.17	8.27-22.54#
	185GG	11.53	7.51-16.81
	187Y2	13.82	11.08-17.67
	149B1	14.77	4.91-27.34
	69Q	27.52	117.28-114.77#
	167H2	31.38	19.35-47.60
	KB54A33-10	32.62	24.76-83.85
	185Z11	34.47	ND
	KB60F5-7	34.67	19.15-124.29
	242K10	34.73	21.08-58.25
	201G	34.90	13.20-355.18#
	204J7	38.57	29.83-48.82
	KB60F5-15	38.62	15.00-2.59E03
	80JJ1	41.96	27.35-139.43
	203J1	43.85	23.18-69.51
	KR589	47.28	29.83-230.71#
	201HH2	49.94	23.83-351.77
	KB60F5-11	51.84	19.38-1313.75#
	158X10	52.25	43.13-77.84#
	KB58A10-3	53.77	ND
	201L3	55.01	41.01-78.96
	158T3	58.07	39.59-211.13
	184M2	60.54	26.57-411.88
	204G4	69.09	52.32-93.83
	KB59A58-4	70.35	48.90-144.90
	201H2	71.11	52.40-130.35
	203G2	81.93	57.13-226.33
	KB59A54-4	82.03	38.50-1.63E03
	204I11	88.41	62.48-173.07
	236B6	89.33	64.16-158.96
	KR1369	93.25	71.97-205.04#
	KB63A5-3	94.52	51.56-542.46
	204C3	125.45	85.26-427.67#
	KR1209	128.14	91.57-294.56
	185W3	130.61	ND
	KR625	160.36	ND
	210B	201.26	48.51-0.14E+06#
	KB10H-5	214.25	87.97-8.22E+03
	KB68B57-1	264.30	48.51-8.95E+04#
	223L2	3.81E+02	ND
	KR136	7.83E+02	—
	T25	1.30E+03	ND
	KB61A18-1	2.58E+03	ND
	147U2	3.67E+03	ND
	KR200	2.14E+05	ND
	KB59A54-5	3.32E+05	ND
	KB3F-3	4.07E+05	ND
	187G1(bs)	3.50E+07	ND
	MR559	20%**	n/a
	KB42C17-13	26%**	n/a
	224F2	33%**	n/a
	KR959	41%**	n/a
	KB2C-4	42%**	n/a
	198H3	46%**	n/a
	KR331	47%**	n/a
	KB46	55%**	n/a
	KB71A118-6	71%**	n/a
	KB53B7-2	84%**	n/a
	187Y2	ND	n/a
	185L12	ND	ND
	186L9	ND	n/a
	KB54A1-6	ND	n/a
	187L14	ND	n/a
	187G1(b)	nt	nt
	187G1(s)	nt	nt

Example 20

Molecular Cloning Expression, and DNA Sequence Analysis of a Novel Binary Endotoxin Gene from Bacillus thuringiensis Strain PS201L3.

[0367] Genomic DNA from PS201 L3 was prepared from cells grown in shake flask culture using a Qiagen Genomic-tip 500/G kit and Genomic DNA Buffer Set according to the protocol for Gram positive bacteria (Qiagen Inc.; Valencia, Calif.). A gene library was constructed from PS201L3 DNA partially digested with Sau3AI. Partial restriction digests were fractionated by agarose gel electrophoresis. DNA fragments 9.3 to 23 kbp in size were

[0368] excised from the gel, electroeluted from the gel slice, purified on an Elutip-D ion exchange column (Schleicher and Schuell, Keene, N.H.), and recovered by ethanol precipitation. The Sau3AI inserts were ligated into BamHI-digested LambdaGem-11 (Promega, Madison, Wis.). Recombinant phage were packaged using Gigapack III XL Packaging Extract (Stratagene, La Jolla, Calif.) and plated on E. coli KW251 cells. Plaques were lifted onto Nytran Nylon Transfer Membranes (Schleicher&Schuell, Keene, N.H.) and probed with a 32P-dCTP labeled gene probe for binary toxin coding sequences. This gene probe was an approximately 1.0 kb PCR product amplified using genomic PS201L3 DNA template and oligonucleotides “15kfor1” and “45krev6.”

[0369] The sequences of the oligonucleotides used for PCR and sequencing follow:

15kfor1	(SEQ ID NO:131)	ATGTCAGCTCGCGAAGTACAC
45krev6	(SEQ ID NO:132)	GTCCATCCCATTAATTGAGGAG

[0370] The membranes were hybridized with the probe overnight at 65° C. and then washed three times with 1×SSPE and 0.1% SDS. Thirteen plaques were identified by autoradiography. These plaques were subsequently picked and soaked overnight in 1 mL SM Buffer+10uL CHCl3. Phage were plated for confluent lysis on KW251 host cells; 6 confluent plates were soaked in SM and used for large-scale phage DNA preparations. The purified phage DNA was digested with various enzymes and run on 0.7% agarose gels. The gels were transferred to Nytran Membranes by Southern blotting and probed with the same PCR-amplified DNA fragment as above. An approximately 6.0 kb hybridizing XbaI band was identified and subcloned into pHT370, an E. coli/Bacillus thuringiensis shuttle vector (Arantes, O., D. Lereclus [1991] Gene 108:115-119) to generate pMYC2476. XL10 Gold Ultracompetent E. coli cells (Stratagene) transformed with pMYC2476 were designated MR1506. PMYC2476 was subsequently transformed into acrytalliferous CryB cells by electroporation and selection on DM3+erythromycin (20ug/mL) plates at 30° C. Recombinant CryB[pMYC2476] was designated MR561.

[0371] A subculture of MR1506 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria,

[0372] Illinois 61604 USA on Jun. 1, 2000. The accession number is B-30298.

[0373] B.t. strain MR561 was examined for expression of the PS201L3 binary toxin proteins by immunoblotting. Cells were grown in liquid NYS-CAA medium+erythromycin (10 ug/ml) overnight at 30° C. The culture was then pelleted by centrifugation and a portion of the cell pellet was resuspended and run on SDS-PAGE gels. Both 14 kDa and 44 kDa proteins were apparent by Western Blot analysis when probed with antibodies specific for either the PS149B1 14 kDa or 44 kDa toxins, respectively.

[0374] DNA sequencing of the toxin genes encoded on pMYC2476 was performed using an

[0375] ABI377 automated sequencer. The DNA sequence for PS201L3 14 kDa gene is shown in SEQ ID NO:133. The deduced peptide sequence for PS201L3 14 kDa toxin is shown in SEQ ID NO:134. The DNA sequence for PS201 L3 44 kDa gene is shown in SEQ ID NO:135. The deduced peptide sequence for PS201 L3 44 kDa toxin is shown in SEQ ID NO:136.

[0376] The following table shows sequence similarity and identity ofbinary genes and proteins from 201 L3 and 149B 1. The program BESTFIT (part of the GCG software package) was used for these comparisons. BESTFIT uses the local homology algorithm of Smith and Waterman (Advances in Applied Mathematics 2: 482-489 (1981)).

	TABLE 14
	201L3 vs 149B1	% similarity	% identity
	14 kDa nucleotide seq	—	71.1
	14 kDa peptide seq	63.9	54.1
	45 kDa nucleotide seq	—	76.1
	45 kDa peptide seq	70.9	62.7

Example 21

Molecular Cloning and DNA Sequence Analysis of Novel 6-Endotoxin Genes from Bacillus thuringiensis Strains PS187G1, PS201HH2 and KR1369

[0377] Total cellular DNA was prepared from Bacillus thuringensis strains PS187G1, PS201HH2 and KR1369 grown to an optical density of 0.5-1.0 at 600 nm visible light in Luria Bertani (LB) broth. DNA was extracted using the Qiagen Genomic-tip 500/G kit and Genomic DNA Buffer Set according to the protocol for Gram positive bacteria (Qiagen Inc.; Valencia, Calif.). PS187G1, PS201HH2 and KR1369 cosmid libraries were constructed in the SuperCosl vector (Stratragene) using inserts of PS187G1, PS201HH2 and KR1369 total cellular DNA, respectively, partially digested with Nde II. XL1-Blue MR cells (Stratagene) were transfected with packaged cosmids to obtain clones resistant to carbenicillin and kanamycin. For each strain, 576 cosmid colonies were grown in 96-well blocks in 1 ml LB+carbenicillin (100 ug/ml)+kanamycin (50 ug/ml) at 37° C. for 18 hours and replica plated onto nylon filters for screening by hybridization.

[0378] PCR amplicon containing approximately 1000 bp of the PS187G1, PS201HH2 or KR1369 14 kDa and 44 kDa toxin operon was amplified from PS187G1, PS201HH2 or KR1369 genomic DNA using primers designed to amplify binary homologs:

15kfor1:	5′-ATG TCA GCT CGC GAA GTA CAC-3′	(SEQ ID NO:131)
45krev6:	5′-GTC CAT CCC ATT AAT TGA GGA G-3′	(SEQ ID NO:132)

[0379] The DNA fragment was gel purified using QiaQuick extraction (Qiagen). The probe was radiolabeled with 32P-dCTP using the Prime-It II kit (Stratgene) and used in aqueous hybridization solution (6×SSPE, 5× Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA) with the colony lift filters at 65° C. for 16 hours. The colony lift filters were briefly washed 1×in 0.5×SSC/0.1% SDS at room temperature followed by two additional washes for 10 minutes at65° C. in 0.5×SSC/0.1% SDS. The filters were then exposed to X-ray film for 20 minutes (PS187G1 and PS201HH2) or for 1 hour (KR1369). One cosmid clone that hybridized strongly to the probe was selected for further analysis for each strain. These cosmid clones were confirmed to contain the approximately 1000 bp 14 kDa and 44 kDa toxin gene target by PCR amplification with the primers listed above. The cosmid clone of PS187G1 was designated as pMYC3106; recombinant E. coli XLl-Blue MR cells containing pMYC3106 are designated MR1508. The cosmid clone of PS201HH2 was designated as pMYC3107; recombinant E. coli XL1-Blue MR cells containing pMYC3107 are designated MR1509. The cosmid clone of KR1369 was designated as pMYC3108; recombinant E. coli XL1-Blue MR cells containing pMYC3108 are designated MR1510. Subcultures of MR1509 and MR1510 were deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Aug. 8, 2000. The accession numbers are NRRL B-30330 and NRRL-B 30331, respectively.

[0380] The PS187G1, PS201HH2 and KR1369 14 kDa and 44 kDa toxin genes encoded by pMYC3106, pMYC3107 and pMYC3108, respectively, were sequenced using the AB1377 automated sequencing system and associated software.

[0381] The PS187G1 14 kDa and 44 kDanucleotide and deduced polypeptide sequences are shown as SEQ ID NOs: 137-140. Both the 14 kDa and 44 kDa toxin gene sequences are complete open reading frames. The PS187G1 14 kDa toxin open reading frame nucleotide sequence, the 44 kDa toxin open reading frame nucleotide sequence, and the respective deduced amino acid sequences are novel compared to other toxin genes encoding pesticidal proteins.

[0382] The PS201HH2 14 kDa and 44 kDa nucleotide and deduced polypeptide sequences are shown as SEQ ID NOs:141-144. The 14 kDa toxin gene sequence is the complete open reading frame. The 44 kDa toxin gene sequence is a partial sequence of the gene. The PS201HH2 14 kDa toxin open reading frame nucleotide sequence, the 44 kDa toxin partial open reading frame nucleotide sequence, and the respective deduced amino acid sequences are novel compared to other toxin genes encoding pesticidal proteins.

[0383] The KR1369 14 kDa and 44 kDa nucleotide and deduced polypeptide sequences are shown as SEQ ID NOs:145-148. Both the 14 kDa and 44 kDa toxin gene sequences are complete open reading frames. The KR1369 14 kDa toxin open reading frame nucleotide sequence, the 44 kDa toxin open reading frame nucleotide sequence, and the respective deduced amino acid sequences are novel compared to other toxin genes encoding pesticidal proteins.

Example 22

Construction and Expression of a Hybrid Gene Fusion Containing the PS149B1 14 kDa and 44 kDa Binary Toxin Genes

[0384] Oligonucleotide primers were designed to the 5′ and 3′ ends of both the 14 kDa and 44 kDa genes from PS149B1. These oligonucleotides were designed to create a gene fusion by SOE-PCR (“Gene Splicing By Overlap Extension: Tailor-made Genes Using PCR,” Biotechniques 8:528-535, May 1990). The two genes were fused together in the reverse order found in the native binary toxin operon (i.e. 44 kDa gene first, followed by the 14 kDa gene.)

[0385] The sequences of the olignucleotides used for SOE-PCR were the following:

F1new:	AAATATTATTTTATGTCAGCACGTGAAGTACACATTG	(SEQ ID NO:155)
R1new:	tctctGGTACCttaTTAtgatttatgcccatatcgtgagg	(SEQ ID NO:156)
F2new:	agagaACTAGTaaaaaggagataaccATGttagatactaataaag	(SEQ ID NO:157)
R2new:	CGTGCTGACATAAAATAATATTTTTTTAATTTTTTTAGTGTACTTT	(SEQ ID NO:158)

[0386] Oligo “F1new” was designed to direct amplification from the 5′ end of the 14 kDa gene and hybridize to the 3′ end of the 44 kDa gene. Oligo “R1new” was designed to direct amplification from the 3′ end of the 14 kDa gene. This primer was designed with two stop codons in order to ensure termination of translation. It was also designed with a KpnI site for directional cloning into a plasmid expression vector for Pseudomonas fluorescens. Oligo “F2new” was designed to direct amplification from the 5′ end of the 44 kDa gene. It also includes a ribosome binding sequence and a SpeI cloning site. Oligo “R2new” was designed to direct amplification from the 3′ end of the 44 kDa gene and hybridize to the 5′ end of the 14 kDa gene.

[0387] The two genes were first independently amplified from PS149B; genomic DNA; the 14 kDa gene using “F1new” and “R1 new,” and the 44 kDa gene using “F2new” and “R2new.” The products were then combined in one PCR tube and amplified togetherusing “R1new” and “F2new.” At this point, HerculaseTM Enhanced Polymerase Blend (Stratagene, La Jolla, Calif.) was used at a 48° C. annealing temperature to amplify a ˜1.5 kb DNA fragment containing the gene fusion. This DNA fragment was subsequently digested using KpnI and SpeI, fractionated on agarose gels, and purified by electroelution. The plasmid vector was also digested with KpnI and SpeI, fractionated on agarose gels, purified by electroelution and treated with phosphatase. The vector and insert were then ligated together overnight at 14° C. Ligated DNA fragments were transformed into MB214 P.f. cells by electroporation and selection overnight on LB+ tetracycline (30 ug/mL) plates. Strains containing the gene fusion were identified by diagnostic PCR and sequenced for verification of successful gene splicing. One representative strain containing the cloned gene fusion was designated MR1607; the recombinant plasmid was designated pMYC2475.

[0388] A subculture of MR1607 was deposited in the permanent collection of the Patent Culture Collection (NRRL), Regional Research Center, 1815 North University Street, Peoria, Ill. 61604 USA on Aug. 8, 2000. The accession number is NRRL B-30332. MR1607 was grown and protein production was verified by SDS-PAGE and immunoblotting. A protein band at ˜58 kDa representing the 44 kDa+14 kDa fusion product was identified when western blots were probed with antibodies specific to either the 14 kDa toxin or the 44 kDa toxin.

[0389] The sequence of the 58 kDa fusion protein is provided in SEQ ID NO:159. The DNA sequence for the gene fusion is provided in SEQ ID NO:160.

Example 23

Binary Homologue Mixing Study Growth of Homologue Strains.

[0390] Four strains were selected, one from each major binary toxin family—149B1, 80JJ1, 201L3, and 167H2. In order to reduce time spent purifying individual toxin proteins, the following Pseudomonas fluorescens (P.f.) clones were grown instead: MR1253 (14 kDa of 149B1) and MR1256 (44 kDa of 149B1). Similarly, B.t. clones MR541 (expressing 14 kDa of 80JJ1), and MR542 (44 kDa of 80JJ1) were used. B.t. strains were grown as described in Example 1. Pellets were washed 3× with water and stored at −20° C. until needed. Pf strains were grown in 10 L batches in Biolafitte fermenters using standard procedures. Pellets were stored at −80° C. until needed.

[0391] Extraction & Purification of Toxins.

[0392] Purification of 167H2, MR541, MR542, 201L3. Extractions of cell pellets were done using 100 mM sodium citrate buffer at pH's ranging from 3.0 to 5.5. In a typical extraction, pellets were extracted with a buffer volume {fraction (1/10)} to ⅓ of the original culture volume. Pellets were suspended in the buffer and placed on a rocking platform at 4° C. for periods of time ranging from 2.5 hours to overnight. The extracts were centrifuged and supernatants were retained. This procedure was repeated with each strain until at least approximately 10 mg of each protein were obtained. SDS-PAGE confirmed the presence/absence of protein toxins in the extracts through use of the NuPAGE Bis/Tris gel system (Invitrogen). Samples were prepared according to the manufacturer's instructions and were loaded onto 4-12% gels and the electrophoretograms were developed with MES running buffer. The exception to this procedure was the sample prep of all 201L3 samples. These samples were prepared by diluting ½× with BioRad's Laemmli sample buffer and heating at 95° C. for 4 minutes. Protein quantitation was done by laser scanning gel densitometry with BSA as a standard (Molecular Dynamics Personal Densitometer SI). Extracts were clarified by filtration through a 0.2 μm membrane filter and stored at 4° C.

[0393] Purification of MR1253 & MR1256. The recombinant proteins MR1253 and MR 1256, corresponding to the 14 and 44 kDa proteins of 149B1 respectively, were prepared as solubilized inclusions. Inclusion bodies were prepared using standard procedures. The inclusion bodies were solubilized in 1 mM EDTA, 50 mM sodium citrate, pH 3.5.

[0394] Purification ofindividual toxins, 167H2 & 201L3. All extracts known to contain either the 14, the 44 kDa, or both were combined. This combined extract was dialyzed against 100 mM sodium citrate, 150 mM NaCl, pH 4. Dialysis tubing was from Pierce (Snakeskin 10k MWCO). Samples were usually dialyzed for approximately 6 hours and then again overnight in fresh buffer.

[0395] Extracts were then concentrated with either Centriprep 10 or Centricon Plus-20 (Biomax-5, 5000 NMWL) centrifugal filter devices (Millipore), quantitated for both the 14 kDa and 44 kDa proteins, and subjected to gel filtration chromatography.

[0396] In preparation for chromatography, all samples and buffers were filtered through a 0.2 μm filter and degassed. Samples were then applied to a HiPrep 26/60 Sephacryl S-100 gel filtration column which had been equilibrated with two bed volumes of the separation buffer, 100 mM sodium citrate, 150 mM NaCl, pH 4.0. Sample volumes ranged from 5-10 ml. An AKTA purifier 100 FPLC system (Amersham Pharmacia) controlled the runs. Chromatography was done at ambient temperature. Buffer flow through the column during the run was maintained at 0.7 ml/min. Proteins were detected by monitoring UV absorbance at 280 nm. Fractions were collected and stored at 4° C. Fractions containing either the 14 or 44 kDa protein were pooled and checked for purity by SDS-PAGE as described above.

[0397] For 167H2 samples, two large peaks were detected and were well separated from each other at the baseline. SDS-PAGE of fractions showed each peak represented one of the protein toxins.

[0398] In the 201 L3 sample, three well defined peaks and one shoulder peak were detected. SDS-PAGE revealed that the first peak represented a 100 kDa protein plus an 80 kDa protein. The second peak represented the 44 kDa protein, while the shoulder peak was a 40 kDa protein. The third peak was the 14 kDa protein. Fractions with the 44 kDa from both samples were combined as were all fractions containing the 14 kDa.

[0399] The 149B1 proteins had been obtained individually from Pf clones MR1253 and MR1256 and, therefore, further purification was not necessary. Similarly, the 80JJ1 recombinants, MR541 and MR542 yielded the individual 14 and 44 kDa proteins thereby obviating further purification.

[0400] Sample Preparation for wCRW LC50 Bioassay.

[0401] Dialysis. Samples of individual binary toxin proteins were dialyzed against 6 L of 20 mM sodium citrate, pH 4.0. The first dialysis proceeded for several hours, the samples were transferred to fresh buffer and alowed to dialyze overnight. Finally, the samples were transferred to fresh buffer and dialyzed several more hours. Sources of the protein samples were either the pooled gel-filtration fractions (167H2, 201L3), pellet extracts (MR541, MR542), or inclusion pellet extracts (MR1253, MR1256). All samples were filtered through 0.2 um membranes to sterilize.

[0402] Concentration. Samples were concentrated with Centricon Plus-20 (Biomax-5, 5000 NMWL) centrifugal filter devices (Millipore).

[0403] Quantitation. Samples were quantitated for protein as above. To meet the requirements of the LC50 bioassay, a minimum of 6.3 mg of each toxin protein were needed at a concentration range of 0.316-1.36 mg/ml for the various combinations. If necessary, samples were concentrated as above, or were diluted with buffer (20 mM sodium citrate, pH 4.0) and requantitated.

[0404] Mixing of binaries/LC50 bioassay. For each of the four strains, the 14 kDa was combined with an amount the 44 kDa of each strain to give a 1/1 mass ratio. The top dose was 50 ug/cm2 for the mixtures, with the exception of mixtures with the 14 kDa protein of 203J1. Top doses of mixtures with this protein were only 44 ug/cm2. For controls, each protein was submitted individually, as was the extract buffer, 20 mM sodium citrate, pH 4.0. Native combinations were also tested (i.e. 14 kDa+44 kDa of 149B1). All toxin combinations and buffer controls were evaluated three times by bioassay against Western corn rootworm, while individual toxins were tested once.

[0405] The results are reported below in Table 15 (LC50 Results for Toxin Combinations) and Table 16 (Comparison of Potencies of Strains to 149B1).

	TABLE 15
	Toxin combination	Top load, ul/well	LC50 (ug/cm2)
	80JJ1 14 + 80JJ1 44	96	28 (19-44 C.I.)
	167H2 44	159	>Top dose
	201L3 44	172	No dose response
	149B1 44	78	No dose response
	167H2 14 + 167H2 44	161	19 (13-27 C.I.)
	80JJ1 44	97	No dose response
	201L3 44	174	14 (10-22 C.I.)
	149B1 44	80	No dose response
	201L3 14 + 201L3 44	193	No dose response
	80JJ1 44	116	No dose response
	167H2 44	180	No dose response
	149B1 44	99	No dose response
	149B1 14 + 149B1 44	45	10 (7-15 C.I.)
	80JJ1 44	63	11 (8-16 C.I.)
	167H2 44	126	8 (6-11 C.I.)
	201L3 44	139	18 (13-27 C.I.)

[0406]

TABLE 16
Comparison of potencies of strains to 149B1
Toxin combination   Relative potency
149B1 14 + 149B1 44 To which all others
                    are compared
149B1 14 + 80JJ1 44 0.9
149B1 14 + 167H2 44 1.3
149B1 14 + 201L3 44 0.5
80JJ1 14 + 80JJ1 44 0.4
167H2 14 + 167H2 44 0.5
167H2 14 + 201L3 44 0.7

[0407] The results are also displayed graphically in FIG. 3.

[0408] Native combinations were highly active against Western corn rootworm, except for 201 L3. However, the 44 kDa of 201L3 was active when combined with either the 14 kDa of 167H2 or 149B1. Other active combinations were the 149B1 14 kDa with either 80JJ1 or 167H2 44 kDa, with the latter appearing to be more active than the native 149B1 mixture. No dose response was noted for either the individual proteins, or the buffer and water controls.

Example 24

Control of Southern Corn Rootworm with PS149B1 14-kDa Protein

[0409] A powder containing approximately 50% (wt/wt) of a 14-kDa 8-endotoxin, originally discovered in Bacillus thuringiensis strain PS149B 1, was isolated from recombinant Pseudomonas fluorescens strain (MR1253). This powder was evaluated for insecticidal activity using the following procedure.

[0410] Artificial insect diet (R. I. Rose and J. M. McCabe (1973), “Laboratory rearing techniques for rearing corn rootworm,” J. Econ. Entomol. 66 (2): 398-400) was dispensed at ˜0.5 mL/well into 128-well bioassay trays (C-D International, Pitman, N.J.) to produce a surface area of ˜1.5 cm2. Buffer (10-mM potassium phosphate, pH 7.5) suspensions of the 14-kDa protein powder were applied to the surface of the artificial insect diet at 50 μL/well, and the diet surface was allowed to dry. Buffer controls were also included in each test. A single neonate southern corn rootworm, Diabrotica undecimpunctata howardi, was placed in each well, and the wells were sealed with lids that were provided with the trays. The bioassays were held for 6 days at 28° C., after which time, the live larvae were weighed as a group for each treatment. Percent growth inhibition was calculated by subtracting the weight of live insects from each treatment from the weight of live, control insects, and then dividing by the control weight. This result was multiplied by 100 to convert the number to a percent. Growth inhibition was calculated for each of 5 tests that each contained 16 insects per treatment, and the growth inhibition was averaged across tests.

[0411] Results demonstrated that the 14-kDa protein inhibited growth of southern corn rootworms in a concentration-dependent manner. Table 17 shows southern corn rootworm growth inhibition with PS149B1 14-kDa protein.

	TABLE 17
		Concentration	% Growth
	Treatment	in μg ai/cm2	Inhibition
	14-kDa Protein	1	32
	14-kDa Protein	3	55
	14-kDa Protein	9	78
	ai = active ingredient

Example 25

Control of European Corn Borer and Corn Earworm with PS149B1 Binary Toxin

[0412] A powder containing 54% of a 14-kDa δ-endotoxin, and another powder containing 37% of a 44-kDa δ-endotoxin, both originally discovered in Bacillus thuringiensis strain PS149B1, were isolated from recombinant Pseudomonas fluorescens strains MR1253 and MR1256, respectively. Mixtures of these powders were evaluated for insecticidal activity using the following procedure.

[0413] Artificial insect diet (R. I. Rose and J. M. McCabe (1973), “Laboratory rearing techniques for rearing corn rootworm,” J. Econ. Entomol. 66 (2): 398-400) was dispensed at ˜0.5 mL/well into 128-well bioassay trays (C-D International, Pitman, N.J.) to produce a surface area of 1.5 cm2. Buffer (10-mM potassium phosphate, pH 7.5) suspensions of the protein powders were mixed, and were then applied to the surface of the artificial insect diet at 50 μL/well. The diet surface was allowed to dry. Buffer controls were also included in each test. A single neonate larvae was placed in each well, and the wells were sealed with lids that were provided with the trays. Tests were conducted with European corn borer, Ostrinia nubilalis, and corn earworm, Helicoverpa zea (both are lepidopterans). The bioassays were held for 6 days at 28° C., after which time, the live larvae were weighed as a group for each treatment. Percent growth inhibition was calculated by subtracting the weight of live insects in each treatment from the weight of live, control insects, and then dividing by the control weight. This result was multiplied by 100 to convert the number to a percent. Growth inhibition was calculated for each of 4 tests that each contained 14 to 16 insects per treatment, and the growth inhibition was averaged across tests.

[0414] Results demonstrated that the 14-kDa protein inhibited growth of European corn borers and corn earworms in a concentration-dependent manner. Table 18 shows corn earworm (CEW) and European corn borer (ECB) growth inhibition with PS149B1 protein mixtures.

TABLE 18
14-kDa protein +	% Growth
44-kDa Protein	Inhibition
Concentration in μg ai/cm2	CEW	ECB
3.7 + 11	42	59
11 + 33	57	77
33 + 100	61	89
ai = active ingredient

Example 26

Further Characterization of the 45 kDa Proteins and Primer Design for Identifying Additional Polynucleotides and Proteins

[0415] The subject invention includes not only the specifically exemplified sequences. Portions of the subject genes and toxins can be used to identify other related genes and toxins. Thus, the subject invention includes polynucleotides that encode proteins or polypeptides comprising at least ten contiguous amino acids, for example, of any of the binary-type proteins or polypeptides included in the attached sequence listing and described herein. Other embodiments include polynucleotides that encode, for example, at least 20, 30, 40, 50, 60, 70, 80, 90, and 100 contiguous amino acids of a protein exemplified herein; these numbers also apply similarly to contiguous nucleotides of an exemplified polynucleotide. The proteins encoded by such polynucleotides are included in the subject invention. Likewise, polynucleotides comprising contiguous nucleotides (that code for proteins or polypeptides comprising peptides of these approximate sizes) are included in the subject invention.

[0416] While still very different, the “closest” toxins to those of the subject invention are believed to be the 51 and 42 kDa mosquitocidal proteins of Bacillus sphaericus. Attached as FIGS. 4 and 5 are protein alignments and nucleotide sequences alignments of the 51 and 42 kDa sphaericus toxins and genes and the 45 kDa 149B1 toxin and gene.

[0417] Two blocks of sequences are highlighted in the nucleotide alignment to which primers could be made. An exemplary PCR primer pair is included below, and in 5′-3′ orientation (45 kD3′rc is shown as the complement). These primers have been successfully used to identify additional members of the 45 kDa binary family. Fully redundant sequences and a prophetic pair are also included below.

45kD5′:   (SEQ ID NO:161)
GAT RAT RAT CAA TAT ATT ATT AC.
45kD3′rc: (SEQ ID NO:162)
CAA GGT ART AAT GTC CAT CC.

[0418] The sequences would be useful as both the sequence written and as the reverse complement (03 and 04 are complementary to 45 kD3′rc, the exemplified reverse primer).

45kD5′01: (SEQ ID NO:163)
GAT GATGrTmrAK wwATTATTrC A.
45kD5′02: (SEQ ID NO:164)
GAT GATGrTmrAT ATATTATTrC A.
45kD3′03: (SEQ ID NO:165)
GGAwG krCdyTwdTm CCwTGTAT.
45kD3′04: (SEQ ID NO:166)
GGAwG kACryTAdTA CCTTGTAT.

[0419] Regarding the manner in which the sphaericus toxins were identified, a BLAST (Altschul et al. (1997), “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Res. 25:3389-3402) database search using the 149B1 45 kDa protein found matches to the 42 kDa B. sphaericus crystal inclusion protein (expectation score 3*10−14) and the 51 kDa B. sphaericus crystal inclusion protein (expectation score 3*10−9).

[0420] An alignment of the 45 kDa 149B 1 peptide sequence to the 42 kDa B. sphaericus crystal inclusion protein results in an alignment having 26% identity over 325 residues. The alignment score is 27.2 sd above the mean score of 100 randomized alignments. A similar analysis of the 45 kDa 149B1 peptide sequence to the 42 kDa B. sphaericus crystal inclusion protein results in an alignment having 29% identity over 229 residues. The alignment score is 23.4 sd above the mean score of 100 randomized alignments. Alignment scores >10 sd above the mean of random alignments have been considered significant (Lipman, D. J. and Pearson, W. R. (1985), “Rapid and sensitive similarity searches,” Science 227:1435-1441; Doolittle, R. F. (1987), Of URFs and ORFs: a primer on how to analyze derived amino acid sequences, University Science Books, Mill Valley, Calif.).

[0421] For reference, the structurally similar Cry1 Aa, Cry2Aa and Cry3Aa protein sequences were compared in the same way. Cry2Aa vs. Cry1Aa and Cry2Aa vs. Cry3Aa share 29% and 27% identity over 214 and 213 residues, respectively, with alignment scores 32.2 sd and 29.5 sd above the mean score of 100 randomized alignments. An alignment of the 149B1 45 kDa protein sequence and the Cry2Aa protein sequence resulted in an alignment score within 1 sd of the mean of 100 randomized alignments.

[0422] The following comparisons are also noted:

TABLE 19
						%	Average
Comparison	Quality	Length	Ratio	Gaps	% Similarity	Identity	Quality*
ps149b1-45.pep x	189	325	0.612	12	35.135	26.351	39.4 ± 5.5
s07712
ps149b1-45.pep x	161	229	0.742	9	36.019	28.910	39.3 ± 5.2
07711
cry2aa1.pep x	182	214	0.888	6	37.688	28.643	43.5 ± 4.3
cry1aa1.pep
cry3aa1.pep x	187	213	0.926	6	40.500	27.000	42.3 ± 4.9
cry2aa1.pep
ps149b1-45.pep x	40	28	1.429	0	42.857	35.714	41.6 ± 5.6
cry2aa1.pep
*based on 100 randomizations

[0423] For further comparison purposes, and for further primer design, the following references are noted:

[0424] Oei et al. (1992), “Binding of purified Bacillus sphaericus binary toxin and its deletion derivatives to Culex quinquefasciatus gut: elucidation of functional binding domains,” Journal of General Microbiology 138(7): 1515-26.

[0425] For the 51 kDa: 35-448 is active; 45-448 is not; 4-396 is active; 4-392 is not.

[0426] For the 42 kDa: 18-370 is active, 35-370 is not; 4-358 is active; 4-349 is not.

[0427] The work was done with GST fusions purified and cleaved with thrombin. All truncations were assayed with ==of other intact subunit. All deletions had some loss of activity. P51 deltaC56 binds, but doesn't internalize 42. P51delta N45 doesn't bind. Only 42 kDa+51 kDa are internalized. Both N-terminal and C-terminal non-toxic 42 kDa proteins failed to bind the 51 kDa protein or 51 kDa-receptor complex.

[0428] Davidson et al. (1990), “Interaction of the Bacillus sphaericus mosquito larvicidal proteins,” Can. J. Microbiol. 36(12):870-8. N-termini of SDS-PAGE purified proteins obtained from B. sphaericus. S29 and N31 of 51 kDa and S9 of 42 kDa in 68-74 kDa complexes (unreduced). S9 and S29 of 51 and N31 of 42 from 51 kDa band (unreduced). In reduced gels the 45 kDa band had S29 and N31 of the 51 kDa and the 39 kDa band contained S9 of the 42 kDa protein.

[0429] Baumann et al. (1988), “Sequence analysis of the mosquitocidal toxin genes encoding 51.4- and 41.9-kilodalton proteins from Bacillus sphaericus 2362 and 2297,” J. Bacteriol. 17:2045-2050. N-termini of 41.9 kDa at D5 from B. sphaericus protease and I11 from chymotrypsin; C-terminus following R349 with trypsin. Regions of enhanced similarity were identified that correspond to many of those above. Similar sequence blocks A through D between the 51 and 42 kDa proteins.

[0430] In summary, the sphaericus toxins discussed above are not meant to be included in the scope of the subject invention (in fact, they are specifically excluded). In that regard, divergent contiguous sequences, as exemplified in the alignments (FIGS. 4 and 5) discussed above, can be used as primers to identify unique toxins that are suggested but not specifically exemplified herein. However, the conserved contiguous sequences, as shown in the alignments, can also be used according to the subject invention to identify further novel 15/45 kDa-type binary toxins (active against corn rootworm and other pests).

Example 27

Insertion and Expression of Toxin Genes In Plants

[0431] One aspect of the subject invention is the transformation of plants with polynucleotides of the subject invention that express proteins of the subject invention. The transformed plants are resistant to attack by the target pest.

[0432] The novel corn rootworm-active genes described here can be optimized for expression in other organisms. For example, maize optimized gene sequences encoding the 14 and 44 kDa PS80JJ1 toxins are disclosed in SEQ ID NO:44 and SEQ ID NO:45, respectively.

[0433] Genes encoding pesticidal toxins, as disclosed herein, can be inserted into plant cells using a variety of techniques which are well known in the art. For example, a large number of cloning vectors comprising a replication system in E. coli and a marker that permits selection of the transformed cells are available for preparation for the insertion of foreign genes into higher plants. The vectors comprise, for example, pBR322, pUC series, M13 mp series, pACYC184, etc. Accordingly, the sequence encoding the B.t. toxin can be inserted into the vector at a suitable restriction site. The resulting plasmid is used for transformation into E. coli. The E. coli cells are cultivated in a suitable nutrient medium, then harvested and lysed. The plasmid is recovered. Sequence analysis, restriction analysis, electrophoresis, and other biochemical-molecular biological methods are generally carried out as methods of analysis. After each manipulation, the DNA sequence used can be cleaved and joined to the next DNA sequence. Each plasmid sequence can be cloned in the same or other plasmids. Depending on the method of inserting desired genes into the plant, other DNA sequences may be necessary. If, for example, the Ti or Ri plasmid is used for the transformation of the plant cell, then at least the right border, but often the right and the left border of the Ti or R1 plasmid T-DNA, has to be joined as the flanking region of the genes to be inserted.

[0434] The use of T-DNA for the transformation of plant cells has been intensively researched and sufficiently described in EP 120 516; Hoekema (1985) In: The Binary Plant Vector System, Offset-durkkerij Kanters B. V., Alblasserdam, Chapter 5; Fraley et al., Crit. Rev. Plant Sci. 4:1-46; and An et al. (1985) EMBO J. 4:277-287.

[0435] Once the inserted DNA has been integrated in the genome, it is relatively stable there and, as a rule, does not come out again. It normally contains a selection marker that confers on the transformed plant cells resistance to a biocide or an antibiotic, such as kanamycin, G 418, bleomycin, hygromycin, or chloramphenicol, inter alia. The individually employed marker should accordingly permit the selection of transformed cells rather than cells that do not contain the inserted DNA.

[0436] A large number of techniques are available for inserting DNA into a plant host cell. Those techniques include transformation with T-DNA using Agrobacterium tumefaciens orAgrobacterium rhizogenes as transformation agent, fusion, injection, biolistics (microparticle bombardment), or electroporation as well as other possible methods. If Agrobacteria are used for the transformation, the DNA to be inserted has to be cloned into special plasmids, namely either into an intermediate vector or into a binary vector. The intermediate vectors can be integrated into the Ti or Ri plasmid by homologous recombination owing to sequences that are homologous to sequences in the T-DNA. The Ti or Ri plasmid also comprises the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate themselves in Agrobacteria. The intermediate vector can be transferred into Agrobacterium tumefaciens by means of a helper plasmid (conjugation). Binary vectors can replicate themselves both in E. coli and in Agrobacteria. They comprise a selection marker gene and a linker or polylinker which are framed by the right and left T-DNA border regions. They can be transformed directly into Agrobacteria (Holsters et al. [1978] Mol. Gen. Genet. 163:181-187). The Agrobacterium used as host cell is to comprise a plasmid carrying a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be contained. The bacterium so transformed is used for the transformation of plant cells. Plant explants can advantageously be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes for the transfer of the DNA into the plant cell. Whole plants can then be regenerated from the infected plant material (for example, pieces of leaf, segments of stalk, roots, but also protoplasts or suspension-cultivated cells) in a suitable medium, which may contain antibiotics or biocides for selection. The plants so obtained can then be tested for the presence of the inserted DNA. No special demands are made of the plasmids in the case of injection and electroporation. It is possible to use ordinary plasmids, such as, for example, pUC derivatives.

[0437] The transformed cells grow inside the plants in the usual manner. They can form germ cells and transmit the transformed trait(s) to progeny plants. Such plants can be grown in the normal manner and crossed with plants that have the same transformed hereditary factors or other hereditary factors. The resulting hybrid individuals have the corresponding phenotypic properties.

[0438] In a preferred embodiment of the subject invention, plants will be transformed with genes wherein the codon usage has been optimized for plants. See, for example, U.S. Pat. No. 5,380,831, which is hereby incorporated by reference. Also, advantageously, plants encoding a truncated toxin will be used. The truncated toxin typically will encode about 55% to about 80% of the full length toxin. Methods for creating synthetic B.t. genes for use in plants are known in the art.

Example 28

Cloning of B.t. Genes Into Insect Viruses

[0439] A number of viruses are known to infect insects. These viruses include, for example, baculoviruses and entomopoxviruses. In one embodiment of the subject invention, genes encoding the insecticidal toxins, as described herein, can be placed within the genome of the insect virus, thus enhancing the pathogenicity of the virus. Methods for constructing insect viruses which comprise B.t. toxin genes are well known and readily practiced by those skilled in the art. These procedures are described, for example, in Merryweather et al. (Merryweather, A. T., U. Weyer, M. P. G. Harris, M. Hirst, T. Booth, R. D. Possee (1990) J. Gen. Virol. 71:1535-1544) and Martens et al. (Martens, J. W. M., G. Honee, D. Zuidema, J. W. M. van Lent, B. Visser, J. M. Vlak (1990) Appl. Environmental Microbiol. 56(9):2764-2770).

[0440] All patents, patent applications, provisional applications, and publications referred to or cited herein are incorporated by reference in their entirety to the extent they are not inconsistent with the explicit teachings of this specification

[0441] It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims.

Claims

1. A polynucleotide that encodes a protein having toxin activity against an insect wherein said polynucleotide was obtained by DNA recombination after random fragmentation of a nucleic acid sequence that encodes an amino acid sequence selected from the group consisting of SEQ ID NO: 76, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:74, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, SEQ ID NO:86, SEQ ID NO:88, SEQ ID NO:90, SEQ ID NO:92, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, SEQ ID NO:102, SEQ ID NO:104, SEQ ID NO:106, SEQ ID NO:108, SEQ ID NO:110, SEQ ID NO:112, SEQ ID NO:114, SEQ ID NO:116, SEQ ID NO:118, SEQ ID NO:120, SEQ ID NO:122, SEQ ID NO:124, SEQ ID NO:126, SEQ ID NO:134, SEQ ID NO:136, SEQ ID NO:138, SEQ ID NO:140, SEQ ID NO:142, SEQ ID NO:144, SEQ ID NO:146, SEQ ID NO:148, SEQ ID No:150, SEQ ID NO: 152, seq id no: 154, and seq id no: 159.

2. An isolated protein having toxin activity against an insect wherein said protein comprises at least ten contiguous amino acids of an amino acid sequence selected from the group consisting of SEQ ID NO:76, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:74, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, SEQ ID NO:86, SEQ ID NO:88, SEQ ID NO:90, SEQ ID NO:92, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO:100, SEQ ID NO:102, SEQ ID NO:104, SEQ ID NO:106, SEQ ID NO:108, SEQ ID NO:110, SEQ ID NO:112, SEQ ID NO:114, SEQ ID NO:116, SEQ ID NO:118, SEQ ID NO:120, SEQ ID NO:122, SEQ ID NO:124, SEQ ID NO:126, SEQ ID NO:134, SEQ ID NO:136, SEQ ID NO:138, SEQ ID NO:140, SEQ ID NO:142, SEQ ID NO:144, SEQ ID NO:146, SEQ ID NO:148, SEQ ID NO:150, SEQ ID NO:152, SEQ ID NO:154, and SEQ ID NO:159.

3. The protein of claim 2 wherein said protein has a molecular weight of approximately 45 kDa.

4. The protein of claim 2 wherein said protein has a molecular weight of approximately 15 kDa.

5. The protein according to claim 2 wherein said protein comprises at least 100 contiguous amino acids of said amino acid sequence.

6. An isolated protein having toxin activity against an insect wherein said protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:76, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:74, SEQ ID NO:78, SEQ ID NO:80, SEQ ID NO:82, SEQ ID NO:84, SEQ ID NO:86, SEQ ID NO:88, SEQ ID NO:90, SEQ ID NO:92, SEQ ID NO:94, SEQ ID NO:96, SEQ ID NO:98, SEQ ID NO: 100, SEQ ID NO: 102, SEQ ID NO:104, SEQ ID NO:106, SEQ ID NO:108, SEQ ID NO:110, SEQ ID NO:112, SEQ ID NO:114, SEQ ID NO:116, SEQ ID NO:118, SEQ ID NO:120, SEQ ID NO:122, SEQ ID NO:124, SEQ ID NO:126, SEQ ID NO:134, SEQ ID NO:136, SEQ ID NO:138, SEQ ID NO:140, SEQ ID NO:142, SEQ ID NO:144, SEQ ID NO:146, SEQ ID NO:148, SEQ ID NO:150, SEQ ID NO:152, SEQ ID NO:154, and SEQ ID NO:159.

7. The polynucleotide of claim 1 wherein said nucleic acid sequence is selected from the group consisting of SEQ ID NO:75, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO:61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO:69, SEQ ID NO:71, SEQ ID NO:73, SEQ ID NO:77, SEQ ID NO:79, SEQ ID NO:81, SEQ ID NO:83, SEQ ID NO:85, SEQ ID NO:87, SEQ ID NO:89, SEQ ID NO:91, SEQ ID NO:93, SEQ ID NO:95, SEQ ID NO:97, SEQ ID NO:99, SEQ ID NO:11, SEQ ID NO:103, SEQ ID NO:105, SEQ ID NO:107, SEQ ID NO:109, SEQ ID NO:11, SEQ ID NO:113, SEQ ID NO:115, SEQ ID NO:117, SEQ ID NO:119, SEQ ID NO:121, SEQ ID NO:123, SEQ ID NO:125, SEQ ID NO:131, SEQ ID NO:132, SEQ ID NO:133, SEQ ID NO:135, SEQ ID NO:137, SEQ ID NO:139, SEQ ID NO:141, SEQ ID NO:143, SEQ ID NO:145, SEQ ID NO:147, SEQ ID NO:149, SEQ ID NO:151, SEQ ID NO:153, SEQ ID NO:155, SEQ ID NO:156, SEQ ID NO:157, SEQ ID NO:158, SEQ ID NO:160, SEQ ID NO:161, SEQ ID NO:162, SEQ ID NO:163, SEQ ID NO:164, SEQ ID NO:165, and SEQ ID NO:166.

8. A protein encoded by a polynucleotide of claim 1.

9. An isolated polynucleotide that encodes a protein of claim 2.

10. A transgenic plant cell comprising a polynucleotide of claim 1.

11. A transgenic plant cell comprising a polynucleotide that encodes a protein of claim 2.

12. A transgenic plant that produces a protein of claim 2.

13. A transgenic plant that produces a protein of claim 8.

14. The plant cell of claim 10 wherein said cell is in a seed.

15. The plant cell of claim 11 wherein said cell is in a seed.

16. A transgenic bacterial cell comprising a polynucleotide of claim 1.

17. A transgenic bacterial cell comprising a polynucleotide that encodes a protein of claim 2.

18. A method of inhibiting an insect wherein said method comprises contacting said insect with a protein of claim 2.

19. A method of inhibiting an insect wherein said method comprises contacting said insect with a protein encoded by a polynucleotide of claim 1.

20. A biologically pure culture of a Bacillus thuringiensis isolate selected from the group consisting of PS185GG, PS187G1, PS187Y2, PS201G, PS201HH2, PS242K10, KB54A1-6, KR589, PS185L12, PS185W3, PS187L14, PS186FF, PS131W2, PS158T3, PS158X10, PS185FF, PS187F3, PS201H2, PS201L3, PS203G2, PS204G4, PS204G4, PS204I11, PS204J7, PS236B6, PS246P42, KR1209, and KR1369.